
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-manuscript.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Discovery of small molecule positive allosteric modulators of the
secretin receptor - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A45000055AA0B899BBE.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="nihpa" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC8146373/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146373/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Biochemical pharmacology" /><meta name="citation_title" content="Discovery of small molecule positive allosteric modulators of the&#10;secretin receptor" /><meta name="citation_author" content="Daniela G. Dengler" /><meta name="citation_author_institution" content="Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA." /><meta name="citation_author" content="Kaleeckal G. Harikumar" /><meta name="citation_author_institution" content="Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona, USA." /><meta name="citation_author" content="Sirkku Pollari" /><meta name="citation_author_institution" content="Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA." /><meta name="citation_author" content="Qing Sun" /><meta name="citation_author_institution" content="Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA." /><meta name="citation_author" content="Brock T. Brown" /><meta name="citation_author_institution" content="Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA." /><meta name="citation_author" content="Aki Shinoki-Iwaya" /><meta name="citation_author_institution" content="Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA." /><meta name="citation_author" content="Robert Ardecky" /><meta name="citation_author_institution" content="Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA." /><meta name="citation_author" content="Laurence J. Miller" /><meta name="citation_author_institution" content="Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona, USA." /><meta name="citation_author" content="Eduard A. Sergienko" /><meta name="citation_author_institution" content="Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA." /><meta name="citation_publication_date" content="2021/03" /><meta name="citation_volume" content="185" /><meta name="citation_firstpage" content="114451" /><meta name="citation_doi" content="10.1016/j.bcp.2021.114451" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC8146373/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC8146373/" /><meta name="citation_pmid" content="33545115" /><meta name="DC.Title" content="Discovery of small molecule positive allosteric modulators of the&#10;secretin receptor" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Daniela G. Dengler" /><meta name="DC.Contributor" content="Kaleeckal G. Harikumar" /><meta name="DC.Contributor" content="Sirkku Pollari" /><meta name="DC.Contributor" content="Qing Sun" /><meta name="DC.Contributor" content="Brock T. Brown" /><meta name="DC.Contributor" content="Aki Shinoki-Iwaya" /><meta name="DC.Contributor" content="Robert Ardecky" /><meta name="DC.Contributor" content="Laurence J. Miller" /><meta name="DC.Contributor" content="Eduard A. Sergienko" /><meta name="DC.Date" content="2021 Mar" /><meta name="DC.Identifier" content="10.1016/j.bcp.2021.114451" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Discovery of small molecule positive allosteric modulators of the&#10;secretin receptor" /><meta property="og:type" content="article" /><meta property="og:description" content="The secretin receptor (SCTR) is a prototypic Class B1 G protein-coupled&#10;receptor (GPCR) that represents a key target for the development of therapeutics&#10;for the treatment of cardiovascular, gastrointestinal, and metabolic disorders.&#10;However, no non-peptidic ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146373/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8146373/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8146373
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8146373/pdf/nihms-1674663.pdf" class="int-view">PDF (4.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8146373/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8146373/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8146373" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8146373%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="BdjTxsGbOWwWHI8sBS0kO2bCKwF1W2X2AOpKO53O8oHTTmOhV3NHEyH5T3mzkTvc">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8146373%2F&amp;text=Discovery%20of%20small%20molecule%20positive%20allosteric%20modulators%20of%20the%0Asecretin%20receptor" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8146373%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146373/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8146373/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/33545115/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8146373/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/33545115/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8146373/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8146373/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8146373
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-nihpa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div><span id="pmcmata">Biochem Pharmacol.</span> Author manuscript; available in PMC 2022 Mar 1.</div><div></div><div class="final-form"><em>Published in final edited form as:</em></div><div class="final-citation"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=33545115" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Biochem Pharmacol. 2021 Mar; 185: 114451. </a></div><span class="fm-vol-iss-date">Published online 2021 Feb 3. </span> <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.bcp.2021.114451" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.bcp.2021.114451</a></span></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC8146373</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS1674663</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33545115">33545115</a></div></div></div><h1 class="content-title">Discovery of small molecule positive allosteric modulators of the
secretin receptor</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Dengler%20DG%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412362938992" co-class="co-affbox">Daniela G. Dengler</a>,<sup>1,</sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Harikumar%20KG%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412322152448" co-class="co-affbox">Kaleeckal G. Harikumar</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pollari%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412323278752" co-class="co-affbox">Sirkku Pollari</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sun%20Q%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412325973168" co-class="co-affbox">Qing Sun</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brown%20BT%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412361426704" co-class="co-affbox">Brock T. Brown</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shinoki-Iwaya%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412362903776" co-class="co-affbox">Aki Shinoki-Iwaya</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ardecky%20R%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412363182256" co-class="co-affbox">Robert Ardecky</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miller%20LJ%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412323413808" co-class="co-affbox">Laurence J. Miller</a>,<sup>2</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sergienko%20EA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140412362822720" co-class="co-affbox">Eduard A. Sergienko</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140412362938992"><h3 class="no_margin">Daniela G. Dengler</h3><p><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Dengler%20DG%5BAuthor%5D">Daniela G. Dengler</a></div></div><div id="_co_idm140412322152448"><h3 class="no_margin">Kaleeckal G. Harikumar</h3><p><sup>2</sup>Department of Molecular Pharmacology and Experimental
Therapeutics, Mayo Clinic, Scottsdale, Arizona, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Harikumar%20KG%5BAuthor%5D">Kaleeckal G. Harikumar</a></div></div><div id="_co_idm140412323278752"><h3 class="no_margin">Sirkku Pollari</h3><p><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pollari%20S%5BAuthor%5D">Sirkku Pollari</a></div></div><div id="_co_idm140412325973168"><h3 class="no_margin">Qing Sun</h3><p><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sun%20Q%5BAuthor%5D">Qing Sun</a></div></div><div id="_co_idm140412361426704"><h3 class="no_margin">Brock T. Brown</h3><p><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brown%20BT%5BAuthor%5D">Brock T. Brown</a></div></div><div id="_co_idm140412362903776"><h3 class="no_margin">Aki Shinoki-Iwaya</h3><p><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shinoki-Iwaya%20A%5BAuthor%5D">Aki Shinoki-Iwaya</a></div></div><div id="_co_idm140412363182256"><h3 class="no_margin">Robert Ardecky</h3><p><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ardecky%20R%5BAuthor%5D">Robert Ardecky</a></div></div><div id="_co_idm140412323413808"><h3 class="no_margin">Laurence J. Miller</h3><p><sup>2</sup>Department of Molecular Pharmacology and Experimental
Therapeutics, Mayo Clinic, Scottsdale, Arizona, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miller%20LJ%5BAuthor%5D">Laurence J. Miller</a></div></div><div id="_co_idm140412362822720"><h3 class="no_margin">Eduard A. Sergienko</h3><p><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sergienko%20EA%5BAuthor%5D">Eduard A. Sergienko</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140412364436768_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140412364436768_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140412364436768_ai" style="display:none"><div class="fm-affl" id="A1"><sup>1</sup>Conrad Prebys Center for Chemical Genomics, Sanford Burnham
Prebys Medical Discovery Institute, La Jolla, California, USA.</div><div class="fm-affl" id="A2"><sup>2</sup>Department of Molecular Pharmacology and Experimental
Therapeutics, Mayo Clinic, Scottsdale, Arizona, USA.</div><div><p id="P1" class="p p-first">Credit Author Statement</p><strong>Daniela G. Dengler:</strong> Conceptualization, Methodology,
Formal analysis, Investigation, Writing - Original Draft, Visualization,
Project administration. <strong>Kaleeckal G. Harikumar:</strong> Validation,
Investigation, Writing - Review &#x00026; Editing. <strong>Sirkku Pollari:</strong>
Investigation, Writing - Review &#x00026; Editing. <strong>Qing Sun:</strong>
Investigation, Writing - Review &#x00026; Editing. <strong>Brock T. Brown:</strong>
Investigation. <strong>Aki Shinoki-Iwaya:</strong> Investigation. <strong>Robert
Ardecky:</strong> Writing - Review &#x00026; Editing. <strong>Laurence J.
Miller:</strong> Writing - Review &#x00026; Editing, Supervision. <strong>Eduard
A. Sergienko:</strong> Writing - Review &#x00026; Editing, Supervision.</div><div id="CR1"><sup>*</sup>Correspondence to:
<a href="mailto:dev@null" data-email="gro.yrevocsidpbs@relgnedd" class="oemail">gro.yrevocsidpbs@relgnedd</a>;
<a href="mailto:dev@null" data-email="gro.yrevocsidpbs@neigrese" class="oemail">gro.yrevocsidpbs@neigrese</a>.</div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140412364436768_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">PMC Copyright notice</a> </div><div><a href="#FN3">Publisher's Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm" role="complementary" aria-label="Related or updated information about this article."><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=33545115" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Biochem Pharmacol</a></div></div></div><div class="sec"></div><div id="ABS1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="ABS1title">Abstract</h2><!--article-meta--><div><p id="P3" class="p p-first-last">The secretin receptor (SCTR) is a prototypic Class B1 G protein-coupled
receptor (GPCR) that represents a key target for the development of therapeutics
for the treatment of cardiovascular, gastrointestinal, and metabolic disorders.
However, no non-peptidic molecules targeting this receptor have yet been
disclosed. Using a high-throughput screening campaign directed at SCTR to
identify small molecule modulators, we have identified three structurally
related scaffolds positively modulating SCTRs. Here we outline a comprehensive
study comprising a structure-activity series based on commercially available
analogs of the three hit scaffold sets A (2-sulfonyl pyrimidines), B (2-mercapto
pyrimidines) and C (2-amino pyrimidines), which revealed determinants of
activity, cooperativity and specificity. Structural optimization of original
hits resulted in analog B2, which substantially enhances signaling of truncated
secretin peptides and prolongs residence time of labeled secretin up to 13-fold
in a dose-dependent manner. Furthermore, we found that investigated compounds
display structural similarity to positive allosteric modulators (PAMs) active at
the glucagon-like peptide-1 receptor (GLP-1R), and we were able to confirm
cross-recognition of that receptor by a subset of analogs. Studies using SCTR
and GLP-1R mutants revealed that scaffold A, but not B and C, likely acts via
two distinct mechanisms, one of which constitutes covalent modification of
Cys-347<sup>GLP&#x02212;1R</sup> known from GLP-1R-selective modulators. The
scaffolds identified in this study might not only serve as novel pharmacologic
tools to decipher SCTR- or GLP-1R-specific signaling pathways, but also as
structural leads to elucidate allosteric binding sites facilitating the future
development of orally available therapeutic approaches targeting these
receptors.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Secretin receptor, positive allosteric modulator, G protein-coupled receptor</span></div></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">1. Introduction</h2><p id="P4" class="p p-first">The secretin receptor (SCTR), the founding member of the secretin-like class
B1 G protein-coupled receptor (GPCR) family, belongs to a small group of 18
receptors naturally activated by moderate-length peptide hormones incorporating
between 27 and 44 amino acid residues [<a href="#R1" rid="R1" class=" bibr popnode">1</a>&#x02013;<a href="#R3" rid="R3" class=" bibr popnode">3</a>]. Members of this
peptide receptor family have well established physiologic functions and potential
therapeutic roles for psychiatric disorders, pain, bone disease, cancer, type 2
diabetes (T2D), obesity and cardiovascular disease [<a href="#R1" rid="R1" class=" bibr popnode">1</a>, <a href="#R4" rid="R4" class=" bibr popnode">4</a>, <a href="#R5" rid="R5" class=" bibr popnode">5</a>]. Despite their widely recognized clinical relevance,
the potential of class B GPCRs has been minimally exploited since only agonists
based on natural peptide ligands have been advanced as therapeutic or diagnostic
agents so far [<a href="#R6" rid="R6" class=" bibr popnode">6</a>, <a href="#R7" rid="R7" class=" bibr popnode">7</a>]. One prominent example are parenterally administered
glucagon-like peptide-1 (GLP-1) mimetics that act by stimulating GLP-1 receptors
(GLP-1Rs) and are currently the most efficient non-surgical treatment for T2D with
positive effects on weight reduction and cardiovascular health [<a href="#R8" rid="R8" class=" bibr popnode">8</a>]. Key mechanisms of GLP-1R signaling are thereby
G&#x003b1;s-induced elevation of cyclic adenosine monophosphate (cAMP) and increased
glucose-sensitive secretion of insulin by pancreatic beta cells. Although peptide
analogs are generally restricted by short half-lives and poor oral bioavailability
[<a href="#R1" rid="R1" class=" bibr popnode">1</a>, <a href="#R9" rid="R9" class=" bibr popnode">9</a>], the development of potent small molecule agonists for this receptor
family has remained elusive, likely due to complex binding mechanisms of natural
orthosteric ligands and the highly open conformation of the extracellular helical
bundle in the active state [<a href="#R1" rid="R1" class=" bibr popnode">1</a>, <a href="#R10" rid="R10" class=" bibr popnode">10</a>, <a href="#R11" rid="R11" class=" bibr popnode">11</a>].</p><p id="P5">Recently, the concept of allosteric modulation, which exploits the interplay
between spatially distinct, but conformationally linked, receptor binding pockets,
has emerged as an opportunity to develop small molecule compounds targeting class B
GPCRs [<a href="#R1" rid="R1" class=" bibr popnode">1</a>]. To overcome the inherent
limitations of peptide-based GLP-1R agonists, T2D drug discovery campaigns have
pursued the search for GLP-1R positive allosteric modulators (PAMs), which led to
the identification of several chemical scaffolds supporting the presence of an
allosteric binding site in GLP-1Rs [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R12" rid="R12" class=" bibr popnode">12</a>&#x02013;<a href="#R16" rid="R16" class=" bibr popnode">16</a>]. <strong>Compound 2</strong> [<a href="#R17" rid="R17" class=" bibr popnode">17</a>]
and <strong>BETP</strong> [<a href="#R12" rid="R12" class=" bibr popnode">12</a>] are two of the
most extensively studied allosteric modulators potentiating GLP-1R-mediated cAMP
accumulation by partial agonists, comprising endogenous stimulators, such as
oxyntomodulin or GLP-1(9&#x02013;36), as well as synthetic peptide analogs and
peptidomimetics [<a href="#R7" rid="R7" class=" bibr popnode">7</a>]. Despite their
structurally distinct chemotypes, both small molecule modulators share an
electrophilic reactivity resulting in covalent modification of a free cysteine
Cys-347 (C347) in the third intracellular loop at the interface between helices 5
and 6 of the receptor [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R18" rid="R18" class=" bibr popnode">18</a>&#x02013;<a href="#R21" rid="R21" class=" bibr popnode">21</a>].
Furthermore, this irreversible stabilization of the receptor in an active state
conformation has been determined to be the driving force of their PAM activity,
since replacing Cys-347 with an alanine at GLP-1Rs did not hamper the signaling of
peptide agonists but eradicated the potentiating effects of both modulators [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R20" rid="R20" class=" bibr popnode">20</a>,
<a href="#R21" rid="R21" class=" bibr popnode">21</a>]. Beyond that, a range of structurally
diverse pharmacophores has been shown to act in a Cys-347-dependent way, revealing
the irreversible mechanism-of-action (MOA) of a majority of GLP-1R PAMs [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R22" rid="R22" class=" bibr popnode">22</a>].
Probably due to their electrophilic function, identified GLP-1R PAMs demonstrated
poor pharmacokinetic properties that terminated their clinical development [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R22" rid="R22" class=" bibr popnode">22</a>].
Attempts to generate potent reversible analogs were challenging, as the creation of
the non-reactive BETP analog <strong>th-BETP</strong>, in which a thioether replaced the
sulfoxide moiety, resulted in a complete loss of activity. Moreover, the existence
of a free cysteine at position 347 in the interface of transmembrane (TM) 5 and 6 is
unique to GLP-1Rs within the class B receptor family [<a href="#R7" rid="R7" class=" bibr popnode">7</a>]. Thus, aiming to develop small molecule compounds targeting this
binding site at other class B GPCRs, such as SCTRs, was not a promising strategy,
even though the quest for allosteric modulators induced a breakthrough in class B
GPCR drug discovery overall.</p><p id="P6">Despite the success of GLP-1 mimetics, bariatric surgery like Roux-en-Y
bypass (RYGB) represents the most effective way to resolve obesity-induced T2D
[<a href="#R23" rid="R23" class=" bibr popnode">23</a>]. In addition to increased GLP-1
levels, a recent study determined that glucose-sensitive S cells in the distal small
intestine may contribute to more than double postprandial secretin plasma
concentrations after RYGB [<a href="#R24" rid="R24" class=" bibr popnode">24</a>]. Secretin
(Sec-FL) is released by S cells reacting to acidic content in the duodenum and
exerts its physiological effects by activating SCTRs [<a href="#R3" rid="R3" class=" bibr popnode">3</a>, <a href="#R25" rid="R25" class=" bibr popnode">25</a>]. Typical for class B
GPCRs, SCTR signaling is predominantly mediated by G&#x003b1;s proteins leading to
enhanced adenylate cyclase activity resulting in an increase of cAMP production.
Primarily known to stimulate biliary and pancreatic secretion, SCTRs have also been
implicated to promote beneficial effects on insulin secretion, cardiac output and
gastric accommodation/emptying [<a href="#R3" rid="R3" class=" bibr popnode">3</a>, <a href="#R9" rid="R9" class=" bibr popnode">9</a>, <a href="#R25" rid="R25" class=" bibr popnode">25</a>,
<a href="#R26" rid="R26" class=" bibr popnode">26</a>]. Beyond that, SCTR activation is
crucial for meal-induced brown fat thermogenesis (BAT) resulting in satiation and
short-term food intake reduction in mice [<a href="#R27" rid="R27" class=" bibr popnode">27</a>]. However, despite the broad implications and potential benefits of SCTR
activation, no ligands other than closely related secretin peptide analogs had been
developed at all [<a href="#R11" rid="R11" class=" bibr popnode">11</a>, <a href="#R25" rid="R25" class=" bibr popnode">25</a>, <a href="#R28" rid="R28" class=" bibr popnode">28</a>&#x02013;<a href="#R30" rid="R30" class=" bibr popnode">30</a>]. In a previous
report [<a href="#R30" rid="R30" class=" bibr popnode">30</a>], we described a testing funnel
directed to identify small molecule compounds acting as positive allosteric
modulators at SCTRs upon binding of secretin peptides. By comparing three different
cAMP detection methods, and evaluating the effects of individual or mixtures of full
and partial peptide agonists utilized as orthosteric stimulator probes in primary
PAM screening efforts, we discovered three related scaffolds (A: 2-sulfonyl
pyrimidines, B: 2-mercapto pyrimidines and C: 2-amino pyrimidines) with substantial
SCTR PAM activity, but with no to minor intrinsic activity and devoid of significant
off-target effects on type 2 arginine vasopressin receptor (AVP2R)-overexpressing or
parental CHO-K1 cell lines.</p><p id="P7">Here we outline intensive structure-activity relationship (SAR) and
allosteric activity studies of the first SCTR PAMs, which enabled the elucidation of
structural components contributing to distinct pharmacological profiles in
SCTR-overexpressing and endogenously expressing cell lines. We identified analog
<strong>B2</strong>, which exerted improved positive cooperativity to partial
secretin peptide agonist Sec(3&#x02013;27) and substantially prolonged secretin
residence time on SCTRs. Being aware of the electrophilic moiety incorporated in
2-sulfonyl pyrimidines (scaffold A), we discovered significant structural
similarities to established GLP-1R small molecule modulators such as
<strong>BETP</strong>. By also screening with GLP-1Rs, we were able to determine
that a subset of SCTR PAMs potentiate not only SCTR activation, but also GLP-1R
signaling. Subsequent evaluation and comparison of cooperativity factors elucidated
distinct receptor and ligand selectivity profiles for each scaffold. We further
confirmed that particularly scaffold A augmented GLP-1R activity in cAMP
accumulation and insulin secretion studies on endogenously receptor expressing INS-1
832/3 cells. To distinguish between irreversible and reversible-acting PAMs, we
deployed glutathione reactivity and cAMP-washout experiments and additionally
generated SCTR and GLP-1R mutants, which were applied to explore the potential
binding sites of newly discovered PAMs.</p><p id="P8" class="p p-last">To our knowledge, this is the first report disclosing the discovery and
comprehensive functional characterization of a novel class of SCTR PAMs, with some
exerting structure-related activity on GLP-1Rs. These newly found agents constitute
not only useful tool compounds to elucidate GLP-1R or SCTR-specific signaling
processes and allosteric binding sites, but also structural leads to advance the
development of orally available therapeutics targeting these important receptors to
eventually treat metabolic disorders, such as obesity and T2D.</p></div><div id="S2" class="tsec sec"><h2 class="head no_bottom_margin" id="S2title">2. Materials and Methods</h2><div id="S3" class="sec sec-first"><h3 id="S3title">2.1. Materials</h3><div id="S4" class="sec sec-first"><p></p><h4 id="S4title" class="inline">2.1.1.  Peptides and compounds: </h4><p id="P9" class="p p-first-last">Sec-FL (full length human secretin (1&#x02013;27), #4031250), GLP-1
(glucagon-like peptide-1 trifluoroacetate salt, #4030663) and AVP
((Arg&#x02078;)-vasopressin trifluoroacetate salt, #4012215) were received
from Bachem AG (Bubendorf, Switzerland). Secretin 1&#x02013;23
(Sec(1&#x02013;23), HSDGTFTSELSRLREGARLQRLL-OH) and Secretin 3&#x02013;27
(Sec(3&#x02013;27), DGTFTSELSRLREGARLQRLLQGLV-NH<sub>2</sub>) were
synthesized by Biopeptide (San Diego, CA, USA). GLP-1(9&#x02013;36)
(GLP-1(9&#x02013;36) amide, #AS-65070) was purchased from Anaspec (Fremont,
CA, USA). BETP
(4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine)
was obtained from Sigma Aldrich (St. Louis, MO, USA, #SML0558, purity
&#x02265;98% (HPLC)). Na<sup>125</sup>Iodine used for secretin peptide
radioiodination was from PerkinElmer (Waltham, MA, USA). Fluorescently
tagged full length secretin (Fluo-Sec) was synthesized as described
previously [<a href="#R30" rid="R30" class=" bibr popnode">30</a>]. Dry powders of
compounds were ordered via MolPort (Beacon, NY, USA) supplied by ChemBridge
Corporation (San Diego, CA, USA), ChemDiv, Inc. (San Diego, CA, USA) or
Vitas-M Laboratory (Champaign, IL, USA) with purity &#x02265; 90%. Compound
IDs correspond to the following MolPort IDs: A1
(MolPort-007&#x02013;583-364), A2 (MolPort-001&#x02013;603-825), A3
(MolPort-001&#x02013;603-762), A4 (MolPort-001&#x02013;603-814), A5
(MolPort-001&#x02013;603-819), A6 (MolPort-001&#x02013;603-826), A7
(MolPort-007&#x02013;583-366), A8 (MolPort-007&#x02013;583-368), A9
(MolPort-001&#x02013;603-798), A10 (MolPort-000&#x02013;162-762), A11
(MolPort-000&#x02013;160-830), A12 (MolPort-002&#x02013;769-455), B1
(MolPort-001&#x02013;603-579), B2 (MolPort-001&#x02013;986-676), B3
(MolPort-002&#x02013;122-137), B4 (MolPort-001&#x02013;986-686), B5
(MolPort-001&#x02013;603-618), B6 (MolPort-001&#x02013;628-009), B7
(MolPort-001&#x02013;985-074), B8 (MolPort-002&#x02013;283-488), C1
(MolPort-001&#x02013;604-034), C2 (MolPort-001&#x02013;603-977), C3
(MolPort-001&#x02013;603-980), C4 (MolPort-001&#x02013;604-037), C5
(MolPort-007&#x02013;589-843), C6 (MolPort-002&#x02013;772-185), C7
(MolPort-002&#x02013;775-111), C8 (MolPort-001&#x02013;604-001), C9
(MolPort-001&#x02013;604-035), C10 (MolPort-001&#x02013;604-036), C11
(MolPort-002&#x02013;775-047) and C13 (MolPort-000&#x02013;433-551). Compound
C12 was obtained by Sundia (SB6308, Shanghai, China). For experiments,
compounds were dissolved in 100% DMSO and stored at room temperature in Echo
Qualified 384-well low dead volume (384LDV) microplates (Labcyte, San Jose,
CA, USA) in a desiccator as 16-point 2-fold dilutions. Compound stock
concentrations ranged from 0 to 10 mM.</p></div><div id="S5" class="sec"><p></p><h4 id="S5title" class="inline">2.1.2.  Cells and culture reagents: </h4><p id="P10" class="p p-first-last">Human Embryonic Kidney (HEK)-293(T), Chinese Hamster Ovary (CHO-K1)
and NG108&#x02013;15 cells were obtained from ATCC (Manassas, VA, USA). INS-1
832/13 rat insulinoma cell line was obtained from Sigma Aldrich (SCC207).
CHO-K1 cells were maintained in CHO cell growth media (Ham&#x02019;s F-12K
(Kaighn&#x02019;s modification), Corning Life Sciences, Tewksbury, MA, USA,
Cellgro #10&#x02013;025-CV), 5% Fetal Bovine Serum (FBS) Clone II (GE
Healthcare Life Sciences, Marlborough, MA, USA, Hyclone #SH30066.03), 1%
penicillin (10,000 units)/ streptomycin (10 mg) (Pen/Strep, Gibco from
Thermo Fisher Scientific, Waltham, MA, USA, #15140122), 1% L-glutamine (200
mM) (Gibco #25030081). HEK-293(T) cells were maintained in HEK cell growth
media (Dulbecco&#x02019;s Modified Eagles Medium (DMEM) Corning Life
Sciences, Cellgro #10&#x02013;013-CV), 10% FBS (Omega Scientific, Tarzana,
CA, USA, #FB-12), 1% Pen/Strep, 1% L-glutamine). Cells were detached using
TrypLE Express (Gibco #12605036). NG108&#x02013;15 cells were maintained in
NG108 growth media consisting of DMEM with 4.5g/L glucose without
L-glutamine and sodium pyruvate, (Corning, #15&#x02013;017-CV), 10% FBS, 1%
L-glutamine, 0.1mM hypoxanthine, 400 nM aminopterin, 0.016mM thymidine
(H.A.T., ATCC, #69-X-2mL), 1.5 g/L sodium bicarbonate (Sigma Aldrich,
#S5761&#x02013;1KG). INS-1 832/13 cells were maintained INS-1 growth media
containing RPMI 1640 without L-glutamine (Corning, #15&#x02013;040-CV), 10%
FBS, 1% Pen/Strep, 1% L-glutamine, 1 mM sodium pyruvate (Gibco,
#11360&#x02013;070), 10 mM HEPES (Gibco, #15630&#x02013;080), 0.05 mM
2-mercapto ethanol (Gibco, #21985&#x02013;023) and 0.3mg/mL G418 (Omega
Scientific, Tarzana, CA, USA, #GN-04).</p></div><div id="S6" class="sec sec-last"><p></p><h4 id="S6title" class="inline">2.1.3.  Receptor constructs: </h4><p id="P11" class="p p-first-last">GLP-1R C347A construct was prepared using Q5 Site-Directed
Mutagenesis Kit (New England Biolabs (NEB), Ipswich, MA) following
manufacturer&#x02019;s protocol. The final product was verified by DNA
sequencing. Secretin receptor constructs, SCTR K317A and SCTR K317C (SCTR
numbering is without the signal sequence (21 amino acid)) were prepared by
oligonucleotide-directed approach using QuikChange site-directed mutagenesis
(Agilent Technologies, Santa Clara, CA), using manufacturer&#x02019;s
instructions, and the products were verified by DNA sequencing.</p></div></div><div id="S7" class="sec sec-last"><h3 id="S7title">2.2. Methods</h3><div id="S8" class="sec sec-first"><p></p><h4 id="S8title" class="inline">2.2.1.  cAMP (cyclic adenosine monophosphate) accumulation assays </h4><p id="P12" class="p p-first">cAMP assays were performed as described previously [<a href="#R30" rid="R30" class=" bibr popnode">30</a>] with minor modifications. In brief,
selectivity screens and allosteric activity studies were performed on frozen
stocks of SCTR- or AVP2R-overexpressing CHO-K1 cells or
GLP-1R-overexpressing HEK-293T cells, all derived from a single cell clone
at a low passage number. After reaching 80&#x02013;90% confluency, cells were
detached using TrypLE Express, centrifuged and re-suspended in freeze media
(10% DMSO in growth media) to dilute to a final concentration of cell stocks
of 20 million cells/mL. Respective ligand standard curves were measured for
each batch of cells to determine adequate EC<sub>20</sub> and
EC<sub>95</sub> concentrations.</p><div id="S9" class="sec"><p></p><h5 id="S9title" class="inline">2.2.1.1.  General procedure: </h5><p id="P13" class="p p-first-last">(using Cisbio cAMP Gs Dynamic HTRF detection kit (Cisbio GsD,
Cisbio US, Inc., Bedford, MA, USA) Orthosteric stimulator dilutions and
titrations were prepared freshly in DMSO and transferred to 384LDV
microplates. Ligands and compounds were dispensed onto dry 1536-well
plate (Corning #3725) with an Echo liquid handler (Labcyte). Frozen cell
stocks were thawed in a water bath at 37&#x000b0;C and immediately
diluted in stimulation buffer (HBSS (Hank&#x02019;s Balanced Salt
Solution with Ca<sup>2+</sup> and Mg<sup>2+</sup>, Gibco #24020117), 5
mM HEPES (hydroxyethyl piperazineethanesulfonic acid), 0.5 mM IBMX
(3-isobutyl-1-methylxanthine, Sigma-Aldrich) and 0.075% BSA (7.5%
DTPA-purified Bovine Serum Albumin, PerkinElmer). 5 &#x003bc;L of cell
suspension were added per well utilizing a Multidrop Combi dispenser
(Thermo Fisher Scientific). The microplate was centrifuged at 1000 rpm
for 1 min, covered with a lid and kept at room temperature (RT) for 30
min. cAMP standard dilutions were prepared in stimulation buffer and
added to designated wells. Detection reagents, cAMP-d2 and anti-cAMP
cryptate, were diluted in cAMP detection buffer and 4 &#x003bc;L were
added per well. The microplate was centrifuged at 1000 rpm for 1 min,
covered with a lid and, after a 30 min incubation at RT, read on a
PHERAstar FSX microplate reader (BMG Labtech, Ortenberg, Germany) using
the HTRF (homogeneous time resolved fluorescence) module.</p></div><div id="S10" class="sec"><p></p><h5 id="S10title" class="inline">2.2.1.2.  Selectivity screens: </h5><p id="P14" class="p p-first-last">In all formats, DMSO was added to obtain the same final DMSO
content in each well. For selectivity studies of compounds, wells
contained 0 &#x02013; 50 &#x003bc;M compound and peptide ligand or DMSO.
Selectivity screening data were uploaded and analyzed on CBIS (Chemical
and Biology Information System software, ChemInnovation Software, Inc.,
San Diego, CA, USA). For PAM assays, EC<sub>20</sub> of ligand and for
agonist assays, DMSO was set as the negative control. EC<sub>95</sub>
served as the positive control in both cases. Further characterization
was conducted using the TIBCO Spotfire software (PerkinElmer).
Experiments were performed in duplicate in three to five independent
experiments. In GLP-1R agonist and PAM formats A2, B1 and C10 have been
tested in duplicate in two independent experiments due to limited
compound availability.</p></div><div id="S11" class="sec"><p></p><h5 id="S11title" class="inline">2.2.1.3.  Allosteric activity studies: </h5><p id="P15" class="p p-first">For allosteric activity studies, wells contained 0 &#x02013; 25
&#x003bc;M of compound and Sec-FL (0&#x02013;100 pM), Sec(1&#x02013;23)
(0&#x02013;100 nM), Sec(3&#x02013;27) (0&#x02013;2.5 &#x003bc;M), GLP-1
(0&#x02013;250 pM) or GLP-1(9&#x02013;36) (0&#x02013;1.25 &#x003bc;M) as
16-point 2-fold dilutions. DMSO was added to obtain the same final DMSO
content in each well. All experiments were performed in duplicate in at
least three independent experiments. TR-FRET ratio values were converted
into cAMP concentrations (nM) employing the cAMP standard curves
recorded with each experiment and the &#x0201c;interpolate the standard
curve&#x0201d; function in GraphPad Prism 8.4.0. For determination of
allosteric activity parameters, the &#x0201c;operational model of
allosterism&#x0201d; (<a href="#FD1" rid="FD1" class=" disp-formula">equation
(1)</a>) was used as described by Leach, K., et al. [<a href="#R31" rid="R31" class=" bibr popnode">31</a>], </p><div class="disp-formula" id="FD1"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="M1"><mrow><mi>R</mi><mi>e</mi><mi>s</mi><mi>p</mi><mi>o</mi><mi>n</mi><mi>s</mi><mi>e</mi><mo>=</mo><mi>b</mi><mi>a</mi><mi>s</mi><mi>a</mi><mi>l</mi><mo>+</mo><mrow><mo>(</mo><mrow><msub><mi>E</mi><mi>m</mi></msub><mo>&#x02212;</mo><mi>b</mi><mi>a</mi><mi>s</mi><mi>a</mi><mi>l</mi></mrow><mo>)</mo></mrow><mo>&#x000d7;</mo><mfrac><mrow><msup><mrow><mrow><mo>(</mo><mrow><msub><mi>&#x003c4;</mi><mi>A</mi></msub><mo stretchy="false">[</mo><mi>A</mi><mo stretchy="false">]</mo><mrow><mo>(</mo><mrow><msub><mi>K</mi><mi>B</mi></msub><mo>+</mo><mi>&#x003b1;</mi><mi>&#x003b2;</mi><mo stretchy="false">[</mo><mi>B</mi><mo stretchy="false">]</mo></mrow><mo>)</mo></mrow><mo>+</mo><msub><mi>&#x003c4;</mi><mi>B</mi></msub><mo stretchy="false">[</mo><mi>B</mi><mo stretchy="false">]</mo><msub><mi>K</mi><mi>A</mi></msub></mrow><mo>)</mo></mrow></mrow><mi>n</mi></msup></mrow><mrow><msup><mrow><mrow><mo>(</mo><mrow><mo stretchy="false">[</mo><mi>A</mi><mo stretchy="false">]</mo><msub><mi>K</mi><mi>B</mi></msub><mo>+</mo><msub><mi>K</mi><mi>A</mi></msub><msub><mi>K</mi><mi>B</mi></msub><mo>+</mo><msub><mi>K</mi><mi>A</mi></msub><mo stretchy="false">[</mo><mi>B</mi><mo stretchy="false">]</mo><mo>+</mo><mi>&#x003b1;</mi><mo stretchy="false">[</mo><mi>A</mi><mo stretchy="false">]</mo><mo stretchy="false">[</mo><mi>B</mi><mo stretchy="false">]</mo></mrow><mo>)</mo></mrow></mrow><mi>n</mi></msup><mo>+</mo><msup><mrow><mrow><mo>(</mo><mrow><msub><mi>&#x003c4;</mi><mi>A</mi></msub><mo stretchy="false">[</mo><mi>A</mi><mo stretchy="false">]</mo><mrow><mo>(</mo><mrow><msub><mi>K</mi><mi>B</mi></msub><mo>+</mo><mi>&#x003b1;</mi><mi>&#x003b2;</mi><mo stretchy="false">[</mo><mi>B</mi><mo stretchy="false">]</mo></mrow><mo>)</mo></mrow><mo>+</mo><msub><mi>&#x003c4;</mi><mi>B</mi></msub><mo stretchy="false">[</mo><mi>B</mi><mo stretchy="false">]</mo><msub><mi>K</mi><mi>A</mi></msub></mrow><mo>)</mo></mrow></mrow><mi>n</mi></msup></mrow></mfrac></mrow></math></div><div class="l">(1)</div></div><p> which is based on the allosteric ternary complex model
presented by Ehlert [<a href="#R32" rid="R32" class=" bibr popnode">32</a>] and the
Black/Leff operational model of agonism [<a href="#R33" rid="R33" class=" bibr popnode">33</a>] (<a href="#FD2" rid="FD2" class=" disp-formula">equation
(2)</a>): </p><div class="disp-formula" id="FD2"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="M2"><mrow><mi>R</mi><mi>e</mi><mi>s</mi><mi>p</mi><mi>o</mi><mi>n</mi><mi>s</mi><mi>e</mi><mo>=</mo><mfrac><mrow><msup><mrow><mo stretchy="false">[</mo><mi>A</mi><mo stretchy="false">]</mo></mrow><mi>n</mi></msup><msubsup><mi>&#x003c4;</mi><mi>A</mi><mi>n</mi></msubsup><msub><mi>E</mi><mi>m</mi></msub></mrow><mrow><msup><mrow><mo stretchy="false">[</mo><mi>A</mi><mo stretchy="false">]</mo></mrow><mi>n</mi></msup><msubsup><mi>&#x003c4;</mi><mi>A</mi><mi>n</mi></msubsup><mo>+</mo><msup><mrow><mrow><mo>(</mo><mrow><mo stretchy="false">[</mo><mi>A</mi><mo stretchy="false">]</mo><mo>+</mo><msub><mi>K</mi><mi>A</mi></msub></mrow><mo>)</mo></mrow></mrow><mi>n</mi></msup></mrow></mfrac></mrow></math></div><div class="l">(2)</div></div><p></p><p id="P16" class="p p-last">The operational model of allosterism comprises the
pharmacological response of allosteric modulator by describing its
concentration [B], equilibrium dissociation constant K<sub>B</sub>,
intrinsic activity &#x003c4;<sub>B</sub>, which incorporates total
receptor density and efficiency of stimulus-response coupling, as well
as cooperativity factors with respect to binding affinity (&#x003b1;) and
efficacy (&#x003b2;). The allosteric modulator effect is dependent on the
orthosteric ligand that is described by concentration [A], equilibrium
dissociation constant K<sub>A</sub> and intrinsic activity
&#x003c4;<sub>A</sub>. E<sub>m</sub> stands for the maximal possible
system response and n denotes the slope factor of the dose-response
curves. By applying the Black/Leff operational model, K<sub>A</sub> and
&#x003c4;<sub>A</sub> were determined for each peptide ligand
dose-response curve without allosteric modulator present. To evaluate
K<sub>B</sub>, &#x003b1; and &#x003b2; for allosteric modulators,
K<sub>A</sub> and &#x003c4;<sub>A</sub>, as well as basal and n were
held constant. In some instances, the &#x0201c;Allosteric EC50
shift&#x0201d; equation in GraphPad Prism (San Diego, CA, USA) had to be
employed to get initial K<sub>B</sub> and &#x003b1; values for
determining cooperativity factor &#x003b2;. &#x003b1;&#x003b2; values
between 0 and 1 describe negative, &#x003b1;&#x003b2; values of 1 neutral,
and &#x003b1;&#x003b2; values higher than 1 denote positive cooperativity
toward the specific receptor-ligand complex investigated.</p></div><div id="S12" class="sec"><p></p><h5 id="S12title" class="inline">2.2.1.4.  Assays with endogenously expressing cell lines: </h5><p id="P17" class="p p-first-last">Following the general protocol, cAMP assays were conducted in
cultured NG108&#x02013;15 or INS-1 832/13 cells with a passage count
between 8&#x02013;17 or 18&#x02013;29, respectively. After reaching
80&#x02013;90% confluency, cells were detached, re-suspended in growth
media, centrifuged at 300xg for 3 min and diluted in stimulation buffer.
For the detection of cAMP accumulation in INS-1 832/13 cells, LANCE
Ultra cAMP detection kit (PerkinElmer) was employed as follows. After
incubation of compound-ligand mixtures with cells at RT for 30 min, 4
&#x003bc;L of 100-fold-diluted Eu-cAMP stock and 300-fold-diluted Ulight
Ab stock in detection buffer was added. TR-FRET signal was recorded
after incubation at RT for 60 min using HTRF module. Assay wells
contained 12.5 or 25 &#x003bc;M of test compound and peptide ligand as
16-point 2-fold dilution, i.e. Sec-FL (0&#x02013; 50 nM),
Sec(1&#x02013;23) (0&#x02013;5 &#x003bc;M) or Sec(3&#x02013;27) (0&#x02013;50
&#x003bc;M) for studies in NG108&#x02013;15 and GLP-1 (0&#x02013;500 nM) or
GLP-1(9&#x02013;36) (0&#x02013;5 &#x003bc;M) for studies in INS-1 832/13
cells. DMSO was added to obtain the same final DMSO content in each
well. All experiments were performed in duplicate in at least three
independent experiments. Curves were fitted using nonlinear regression
equation &#x0201c;[Agonist] vs. response -- Variable slope (four
parameters)&#x0201d; in GraphPad Prism 8.4.0.</p></div><div id="S13" class="sec"><p></p><h5 id="S13title" class="inline">2.2.1.5.  Co-incubation versus pre-incubation: </h5><p id="P18" class="p p-first-last">In general, compounds and ligand were dispensed onto dry
microplates and co-incubated with cells for 30 min at RT before addition
of detection reagent. In case of mutational studies, allosteric activity
studies employing HEK-293T-GLP-1R cells and GLP-1(9&#x02013;36) as well
as for studies in INS-1 832/12 cells, group A compounds and BETP were
added after a 10&#x02013;20 min pre-incubation of ligand at RT to achieve
maximal compound response.</p></div><div id="S14" class="sec"><p></p><h5 id="S14title" class="inline">2.2.1.6.  Wash-out experiments: </h5><p id="P19" class="p p-first-last">Wash-out experiments were performed according to general
procedure with the following modifications: A frozen vial of
SCTR-overexpressing CHO-K1 cells or GLP-1R-overexpressing HEK-293T cells
was thawed quickly at 37 &#x000b0;C and diluted in growth media to obtain
desired cell densities. Cells were dispensed 5 &#x003bc;L per well into
TC-treated 384-well microplates (Greiner Bio-One small volume 784080).
For HEK-293-GLP-1R cells, Poly-D-Lysine coated microplates were
employed. Plates were centrifuged at 500 rpm for 15 sec, covered with a
lid and incubated overnight at 37 &#x000b0;C and 5% CO<sub>2</sub>. 25
&#x003bc;M of compounds or DMSO were added to one half of the plate,
followed by 20&#x02013;30 min incubation at RT. Subsequently,
compound-containing media was removed and cells were washed three times
with PBS (CHO-SCTR) or HBSS (HEK-293T-GLP-1R) using BlueWasher (Blue Cat
Bio, Concord, MA, USA). 5 &#x003bc;L of stimulation buffer was added per
well, plates were centrifuged 500 rpm for 1 min and 25 &#x003bc;M of
compounds or DMSO were added to the second half of the plate. On top,
peptide ligands (Sec-FL (0&#x02013;100 pM) or GLP-1 (0&#x02013;250 pM)) as
16-point 2-fold dilutions were dispensed across the microplate. After
centrifugation at 1000 rpm at 1 min, plates were incubated at RT for 30
min. Detection of cAMP accumulation was conducted following the general
protocol but dispensing 5 &#x003bc;L of detection mixture per well. All
experiments were performed in duplicate in at least three independent
experiments. Curves were fitted using nonlinear regression equation
&#x0201c;[Agonist] vs. response -- Variable slope (four
parameters)&#x0201d; in GraphPad Prism 8.4.0.</p></div><div id="S15" class="sec sec-last"><p></p><h5 id="S15title" class="inline">2.2.1.7.  Mutational studies: </h5><p id="P20" class="p p-first-last">Receptor mutant constructs were characterized in cAMP assays
following the general procedure with few minor modifications: HEK-293
cells in HEK cell growth media were seeded in 6-well TC-plates and
incubated overnight at 37 &#x000b0;C and 5% CO<sub>2</sub>. SCTR WT
(wildtype), SCTR K317A, SCTR K317C, GLP-1R WT or GLP-1R C347A were
transfected using TransIT&#x000ae;-LT1 transfection reagent following
manufacturer&#x02019;s manual (Mirus Bio, Madison, WI, USA) delivering 1
&#x003bc;g DNA of SCTR construct or 0.5 &#x003bc;g DNA of GLP-1R construct
per well. After 24 h at 37 &#x000b0;C and 5% CO<sub>2</sub>, cells
expressing receptor constructs were harvested using TrypLE Express,
centrifuged at 300 g for 3 min and diluted in stimulation buffer. 5
&#x003bc;L of cells were added per well to a 1536-well microplate
(Corning #3725), which already contained DMSO or 12.5&#x02013;25
&#x003bc;M of test compound. Plates were centrifuged for 1 min at 1000
rpm. After a 10&#x02013;20 min incubation at RT, peptide ligand (Sec-FL
0&#x02013;100 pM, Sec(1&#x02013;23) 0&#x02013;100 nM, Sec(3&#x02013;27)
0&#x02013;2.5 &#x003bc;M, GLP-1 0&#x02013;250 pM, GLP-1(9&#x02013;36)
0&#x02013;1.25 &#x003bc;M) as 16-point 2-fold dilutions were dispensed on
top. After centrifugation at 1000 rpm at 1 min, plates were incubated at
RT for 30 min. Detection of cAMP accumulation was conducted following
the general protocol. All experiments were performed in duplicate in at
least three independent experiments. Curves were fitted using nonlinear
regression equation &#x0201c;[Agonist] vs. response -- Variable slope
(four parameters)&#x0201d; in GraphPad Prism 8.4.0.</p></div></div><div id="S16" class="sec"><p></p><h4 id="S16title" class="inline">2.2.2.  TR-FRET SNAP-SCTR binding </h4><p id="P21" class="p p-first">Binding experiments were performed as previously described [<a href="#R30" rid="R30" class=" bibr popnode">30</a>], with the following
modifications:</p><div id="S17" class="sec"><p></p><h5 id="S17title" class="inline">2.2.2.1.  Competition binding: </h5><p id="P22" class="p p-first-last">Equilibrium dissociation constant K<sub>D</sub> of Sec-Fluo was
determined by saturation binding experiments described in our previous
report [<a href="#R30" rid="R30" class=" bibr popnode">30</a>]. For evaluation of
competition binding, Fluo-Sec and Sec-FL were diluted in DMSO and
dispensed into a 384LDV plate. Ligand titrations were prepared in DMSO
in adjacent wells. Fluo-Sec was added (6 nM final) to all test wells of
a 1536-well plate (Corning #3725). DMSO (in positive control wells),
Sec-FL (5 &#x003bc;M final, negative control wells) or ligand/compound
titrations (Sec-FL (0&#x02013;500 nM), test compounds (0&#x02013;50
&#x003bc;M), 16-point 2-fold dilutions) were dispensed on top. Using a
dounce homogenizer HEK-293 SNAP-SCTR membranes, thawed at RT and
pre-labeled with Lumi-4 Terbium cryptate (Cisbio Tag-lite), were diluted
in binding buffer (10 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM
MgCl<sub>2</sub>, 1 mM ascorbic acid, 0.2% BSA). Membrane solution
was added at 5 &#x003bc;L per well. The microplate was centrifuged 1000
rpm for 1 min and incubated for 2 h at RT. Fluo-Sec bound to SNAP-SCTRs
was recorded by PHERAstar FSX (LanthaScreen module). Data was uploaded
and analyzed via CBIS to report EC<sub>50</sub> and efficacy values with
respect to in- or decrease of Fluo-Sec receptor binding for compounds or
Sec-FL, respectively. Experiments were performed in duplicate in three
to five independent experiments.</p></div><div id="S18" class="sec sec-last"><p></p><h5 id="S18title" class="inline">2.2.2.2.  Dissociation binding </h5><p id="P23" class="p p-first-last">Fluo-Sec (10 nM final) was dispensed into a 1536-well plate
(Corning #3725). For negative control wells Sec-FL (5 &#x003bc;M final)
and for positive control wells and sample wells DMSO were added on top.
With a dounce homogenizer thawed HEK-293 SNAP-SCTR membranes were
diluted in binding buffer (10 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM
MgCl<sub>2</sub>, 1 mM ascorbic acid, 0.2% BSA). Membrane suspension
was added at 5 &#x003bc;L/well and the microplate was centrifuged for 1
min at 1000 rpm. After 2 h incubation at RT, the plate was read for
baseline fluorescence using PHERAstar FSX. DMSO (negative control) or
test compounds (3.1, 6.25 or 12.5 &#x003bc;M) were dispensed into sample
wells and after centrifugation at 1000 rpm for 1 min, the microplate was
read with PHERAstar FSX. Immediately, dissociation buffer (binding
buffer, 5 &#x003bc;M Sec-FL, 100 &#x003bc;M GTP&#x003b3;S) was dispensed
into sample wells and binding buffer was added to control wells.
Dissociation binding was detected using PHERAstar FSX (LanthaScreen,
kinetic mode, 10 cycles, 45 min). Dissociation half-lives
(t<sub>1/2</sub> [min]) were determined using GraphPad Prism 8.4.0
applying equation &#x0201c;Dissociation &#x02013; One phase exponential
decay&#x0201d;. Experiments were performed in triplicates in at least
three independent experiments.</p></div></div><div id="S19" class="sec"><p></p><h4 id="S19title" class="inline">2.2.3.  Glucose stimulated insulin secretion (GSIS) assay </h4><p id="P24" class="p p-first-last">GSIS was performed according to Merglen, A., et al. [<a href="#R34" rid="R34" class=" bibr popnode">34</a>] with the following modifications: INS-1
832/13 were maintained in INS-1 growth media. After reaching 80&#x02013;90%
confluency, cells were harvested using TrypLE Express and diluted in growth
media. 25 &#x003bc;L of cells were seeded per well into a 384-well TC-treated
microplate (Greiner 781098). After 2 days at 37 &#x000b0;C and 5%
CO<sub>2</sub>, media was displaced with 21 &#x003bc;L of glucose-free
INS-1 growth media using Blue Cat Bio Blue Washer. Microplate was
centrifuged at 500 rpm for 15 sec and incubated at 37 &#x000b0;C and 5%
CO<sub>2</sub> for 2 h. Media was displaced with 21 &#x003bc;L of KRSHB
buffer (Krebs-Ringer Solution, HEPES-buffered (Alfa Aesar, Haverhill, MA,
USA) containing 120 mM sodium chloride, 5 mM potassium chloride, 2 mM
calcium chloride, 1 mM magnesium chloride, 25 mM sodium bicarbonate, 5.5 mM
HEPES and 1.1 mM D-glucose with addition of 0.1% BSA). Microplate was
centrifuged at 500 rpm for 15 sec, incubated at 37 &#x000b0;C and 5%
CO<sub>2</sub> for 1 h and the BlueWasher step was repeated leaving 21
&#x003bc;L of KRSHB buffer. Test compounds (6.25x for 20 &#x003bc;M final) or
DMSO and GLP-1(9&#x02013;36) (6.25x for 1 &#x003bc;M final) or DMSO had been
dispensed into a Corning NBS (non-binding surface) 384 well microplate and
were diluted with KRSHB buffer containing additional glucose (6.25x for 15
mM final). 4 &#x003bc;L of compound-ligand mixtures were transferred to the
assay plate, which was subsequently centrifuged at 500 rpm for 15 sec and
incubated for 2 h at 37 &#x000b0;C and 5% CO<sub>2</sub> followed by 15 min
at RT. The Insulin High Range Kit (Cisbio) was employed for quantification
of secreted insulin according to manufacturer&#x02019;s instructions. Insulin
standard, diluent and detection reagents were prepared on ice according to
manufacturer&#x02019;s instructions. 5 &#x003bc;L of conditioned media were
transferred per well into a cooled 384 well NBS microplate (Corning). 45
&#x003bc;L of diluent (Cisbio) were added on top of each well, followed by
centrifugation at 1000 rpm for 1 min. 1 &#x003bc;L of the 10-fold diluted
media was transferred per well into a cooled white 384 well small volume
microplate (Greiner), which contained 1 &#x003bc;L of the insulin standard
titration in adjacent wells. After addition of 15 &#x003bc;L ice-cold
detection mixture (Cisbio), the small volume plate was spun at 1000 rpm for
1 min, sealed with foil and incubated in the dark overnight. The plate was
read using PHERAstar FSX (HTRF). Experiments were performed as
quintuplicates in three independent experiments. Insulin concentrations were
calculated in Excel using TR-FRET ratio values and the insulin standard
curve equation: Insulin concentration (ng/mL) = ((0.0000003)*(TR-FRET
ratio)<sup>2</sup>)+(0.0006*TR-FRET ratio)+0.6336; R<sup>2</sup> =
0.9988. Values were multiplied by 10 to determine insulin secretion as ng/mL
per source well and plotted as bar graphs using GraphPad Prism 8.4.0.
Statistical significance of compound and ligand treatment as well as of
interactions between compound and ligand treatment were determined using
ordinary two-way ANOVA and Tukey&#x02019;s multiple comparisons test with
individual variances computed for each comparison (99% confidence interval).
P values were illustrated according to the following classification: (*)
adjusted P values between 0.01 and 0.05, (**) adjusted P values between 0.01
and 0.001, (***) adjusted P values between 0.001 and 0.0001, (****) adjusted
P values &#x0003c;0.0001.</p></div><div id="S20" class="sec"><p></p><h4 id="S20title" class="inline">2.2.4.  Cell culture and transfections for receptor mutant-binding assays </h4><p id="P25" class="p p-first-last">SCTR constructs were transiently expressed in African green monkey
kidney (COS-1) cells. Cells were grown in sterile 10 cm tissue culture
plates in DMEM media supplemented with 5% Fetal Clone II, 1% penicillin and
streptomycin mixture in a 37 &#x000b0;C incubator in a humidified environment
containing 5% carbon dioxide. At an approximate confluence of 80 percent,
the cells were transfected with 1.0 &#x003bc;g of DNA per dish using the
diethylaminoethyl (DEAE)-dextran method [<a href="#R35" rid="R35" class=" bibr popnode">35</a>].</p></div><div id="S21" class="sec"><p></p><h4 id="S21title" class="inline">2.2.5.  Receptor mutant-binding assays </h4><p id="P26" class="p p-first-last">Receptor expressing COS-1 cells were incubated with ~5 pM
<sup><em>125</em></sup><em>I-Tyr</em><sup><em>10</em></sup>-secretin
(prepared and purified in our laboratory to yield approximate specific
radioactivity of 2,000 Ci/mmol) in the absence or presence of increasing
concentrations (0 to 0.1 &#x003bc;M) of unlabeled secretin peptide for 1 h at
room temperature in KRH medium (25 mM HEPES, pH 7.4, 104 mM NaCl, 5 mM KCl,
2 mM CaCl<sub>2</sub>, 1 mM KH<sub>2</sub>PO<sub>4</sub>, 1.2 mM
MgSO<sub>4</sub>) pH 7.4, containing 0.01% soybean trypsin inhibitor and
0.2% bovine serum albumin. The receptor-bound fraction was washed with
ice-cold KRH medium containing 0.01% soybean trypsin inhibitor and 0.2%
bovine serum albumin to separate free from receptor bound ligand, and were
subsequently lysed with 0.5 M NaOH. Receptor bound radioactivity was
quantified in a &#x003b3;&#x02013;counter with approximate 70% counting
efficiency. Competition-binding studies were performed in duplicate and
repeated in at least three independent experiments. Non-specific binding was
determined in the presence of 0.1 &#x003bc;M unlabeled secretin and
represented less than 15% of total binding. Saturable binding data was
analyzed using the non-linear least-squares curve-fitting routine in Prism
6.0 (GraphPad, San Diego, CA).</p></div><div id="S22" class="sec sec-last"><p></p><h4 id="S22title" class="inline">2.2.6.  Covalent reactivity with Glutathione (GSH) </h4><p id="P27" class="p p-first-last">In 1.5 mL Eppendorf tubes 100 &#x003bc;L of GSH (Sigma Aldrich, 10 mM
stock in PBS, 4 mM final, 2 eq.), 50 &#x003bc;L of compound <strong>A1</strong>
or <strong>B2</strong> (10 mM stock in DMSO, 2 mM final) and 100 &#x003bc;L of
DMSO were mixed and incubated at 37 &#x000b0;C. Control reactions in PBS/DMSO
(1:1.5, 250 &#x003bc;L) containing compounds or GSH only were prepared in
parallel. After 5 min and after 4 h, samples (20 &#x003bc;L) of the reaction
mixtures were taken, diluted in 1 mL of DMSO and presence of GS-adduct
formation was monitored using Waters Acquity UPLC/MS (Phenomenex Kinetex C18
2.6 &#x003bc;M, 20 &#x000d7; 2.1 mm; flow 0.8 mL/min; linear gradient in water
(0.05% formic acid): 10% to 99% methanol (0.05% formic acid) in 2 min, 99%
methanol (0.05% formic acid) for 0.8 min, 99% to 10% methanol (0.05% formic
acid) in 0.7 min; t<sub>R</sub>: 3.5 min) by comparing molecular weights of
compounds and putative compound-glutathione adducts.</p></div></div></div><div id="S23" class="tsec sec"><h2 class="head no_bottom_margin" id="S23title">3. Results</h2><div id="S24" class="sec sec-first"><h3 id="S24title">3.1. Structure-activity relationships of SCTR PAM scaffolds elucidate key
structural components for compound activity</h3><p id="P28" class="p p-first">We previously established and validated a SCTR screening platform and
demonstrated its ability to identify PAMs, although specific structures have not
previously been disclosed [<a href="#R27" rid="R27" class=" bibr popnode">27</a>]. We got
particularly interested in three scaffold sets, which shared a structural motif
and were described as A: 2-sulfonyl pyrimidines, B: 2-mercapto pyrimidines and
C: 2-amino pyrimidines. The three compound groups differ mainly in their
substituents at ring A, their substituent and corresponding reactivity at
position 2, as well as the length and nature of the linker connecting to a third
aromatic moiety (Ar) (<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). The
original screening hits showed significant SCTR PAM activity, but no to minor
intrinsic activity and negligible off-target effects on non-receptor bearing
parental cell lines or on type 2 arginine vasopressin receptor
(AVP2R)-overexpressing cells used as a class A GPCR counterpart that is also
coupled with Gs proteins.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>Table 1:</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Structure-activity studies of 33 analogs in functional selectivity screens
and SNAP-SCTR binding assays.</strong><p id="P68">Average potencies (EC<sub>50</sub> [&#x003bc;M] &#x000b1; standard
deviation (SD)) and average compound efficacy (E<sub>max</sub> [%] &#x000b1; SD)
of compound dose response studies in screening mode. Compounds were tested in
Cisbio GsD cAMP accumulation assays and SNAP-SCTR binding experiments; NT: not
tested; n.d.: not detected (response less than mean &#x000b1; 3xSD of negative
control); data analysis via CBIS and Microsoft Excel; experiments were performed
in duplicates in three to five independent experiments.</p></div><div class="xtable"><table frame="below" rules="groups" class="rendered small default_table"><thead><tr><th colspan="22" align="center" valign="middle" rowspan="1"><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0010.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0010.jpg" /><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0011.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0011.jpg" /><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0012.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0012.jpg" /><hr /></th></tr><tr><th colspan="8" align="center" valign="middle" rowspan="1">Structural
specifications</th><th colspan="2" align="center" valign="middle" rowspan="1">SCTR PAM (3-pep mix)</th><th colspan="2" align="center" valign="middle" rowspan="1">SCTR Sec-FL (PAM)</th><th colspan="2" align="center" valign="middle" rowspan="1">SCTR agonist</th><th colspan="2" align="center" valign="middle" rowspan="1">SNAP-SCTR Binding</th><th colspan="2" align="center" valign="middle" rowspan="1">AVP PAM (AVP)</th><th colspan="2" align="center" valign="middle" rowspan="1">GLP-1R PAM (GLP-1)</th><th colspan="2" align="center" valign="middle" rowspan="1">GLP-1R agonist</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">CMPD ID</th><th align="center" valign="middle" rowspan="1" colspan="1">R<sup>1</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">R<sup>2</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">R<sup>3</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">X</th><th align="center" valign="middle" rowspan="1" colspan="1">n</th><th align="center" valign="middle" rowspan="1" colspan="1">Y</th><th align="center" valign="middle" rowspan="1" colspan="1">Ar</th><th align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> [&#x003bc;M]</th><th align="center" valign="middle" rowspan="1" colspan="1">E<sub>max</sub> [%]</th><th align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> [&#x003bc;M]</th><th align="center" valign="middle" rowspan="1" colspan="1">E<sub>max</sub> [%]</th><th align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> [&#x003bc;M]</th><th align="center" valign="middle" rowspan="1" colspan="1">E<sub>max</sub> [%]</th><th align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> [&#x003bc;M]</th><th align="center" valign="middle" rowspan="1" colspan="1">E<sub>max</sub> [%]</th><th align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> [&#x003bc;M]</th><th align="center" valign="middle" rowspan="1" colspan="1">E<sub>max</sub> [%]</th><th align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> [&#x003bc;M]</th><th align="center" valign="middle" rowspan="1" colspan="1">E<sub>max</sub> [%]</th><th align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> [&#x003bc;M]</th><th align="center" valign="middle" rowspan="1" colspan="1">E<sub>max</sub> [%]</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A1</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327698880"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0013.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0013.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0013.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412327698880"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.7</strong> &#x000b1; 4.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>60</strong> &#x000b1; 16</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>8.5</strong> &#x000b1; 6.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>45</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>32</strong> &#x000b1; 5.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.3</strong> &#x000b1; 3.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>137</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 17</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>12</strong> &#x000b1; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>49</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>22</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>77</strong> &#x000b1; 51</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A2</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412322964800"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0014.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0014.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0014.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412322964800"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>8.0</strong> &#x000b1; 4.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>72</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>12</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>55</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>29</strong> &#x000b1; 16</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.2</strong> &#x000b1; 1.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>144</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 20</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 7.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>11</strong> &#x000b1; 5.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>57</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>70</strong> &#x000b1; 29</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A3</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412361817120"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0015.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0015.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0015.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412361817120"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.0</strong> &#x000b1; 3.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>40</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>21</strong> &#x000b1; 4.5</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>11</strong> &#x000b1; 8.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>149</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.7</strong> &#x000b1; 3.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>62</strong> &#x000b1; 43</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.3</strong> &#x000b1; 4.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>48</strong> &#x000b1; 19</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A4</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412325526608"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0016.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0016.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0016.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412325526608"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.7</strong> &#x000b1; 5.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>41</strong> &#x000b1; 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>12</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>21</strong> &#x000b1; 3.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 18</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>13</strong> &#x000b1; 2.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.8</strong> &#x000b1; 2.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>142</strong> &#x000b1; 5.9</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.3</strong> &#x000b1; 4.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>58</strong> &#x000b1; 34</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>4.4</strong> &#x000b1; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>46</strong> &#x000b1; 15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A5</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412362566592"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0017.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0017.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0017.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412362566592"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>8.4</strong> &#x000b1; 4.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>43</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; 18</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>23</strong> &#x000b1; 3.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 9.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>22</strong> &#x000b1; 6.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.4</strong> &#x000b1; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>138</strong> &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>38</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>25</strong> &#x000b1; 6.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.4</strong> &#x000b1; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 18</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.2</strong> &#x000b1; 3.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>49</strong> &#x000b1; 15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A6</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327214448"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0018.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0018.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0018.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412327214448"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>12</strong> &#x000b1; 5.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>77</strong> &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>61</strong> &#x000b1; 29</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>24</strong> &#x000b1; 7.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>25</strong> &#x000b1; 8.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.8</strong> &#x000b1; 3.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>148</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>13</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 8.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>12</strong> &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>61</strong> &#x000b1; 27</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; 2.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>61</strong> &#x000b1; 26</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A7</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412321807184"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0019.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0019.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0019.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412321807184"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>8.4</strong> &#x000b1; 2.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>31</strong> &#x000b1; 5.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>12</strong> &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 3.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>45</strong> &#x000b1; 7.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.2</strong> &#x000b1; 2.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>128</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>46</strong> &#x000b1; 6.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>29</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>28</strong> &#x000b1; 18</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>64</strong> &#x000b1; 30</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>9.5</strong> &#x000b1; 3.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>36</strong> &#x000b1; 14</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A8</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412364316176"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0020.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0020.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0020.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412364316176"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>13</strong> &#x000b1; 5.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>63</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>30</strong> &#x000b1; 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>27</strong> &#x000b1; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.9</strong> &#x000b1; 2.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>128</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>44</strong> &#x000b1; 4.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>52</strong> &#x000b1; 3.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>57</strong> &#x000b1; 31</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>56</strong> &#x000b1; 37</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A9</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412326436496"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0021.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0021.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0021.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412326436496"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.4</strong> &#x000b1; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>11</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>38</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.8</strong> &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>147</strong> &#x000b1; 30</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>48</strong> &#x000b1; 3.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.7</strong> &#x000b1; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>32</strong> &#x000b1; 13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A10</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">OH</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>28</strong> &#x000b1; 16</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 4.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>40</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.6</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>29</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>14</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>39</strong> &#x000b1; 8.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A11</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">F</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">ethyl</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>38</strong> &#x000b1; 8.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>76</strong> &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 5.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>118</strong> &#x000b1; 15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>A12</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">methyl</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 8.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>49</strong> &#x000b1; 18</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>28</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>29</strong> &#x000b1; 3.3</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>33</strong> &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>104</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>16</strong> &#x000b1; 2.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>71</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>11</strong> &#x000b1; 6.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>75</strong> &#x000b1; 21</td></tr><tr><td colspan="22" align="center" valign="middle" rowspan="1"><hr /></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B1</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">CH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412325479040"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0022.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0022.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0022.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412325479040"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.6</strong> &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>47</strong> &#x000b1; 16</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>1.3</strong> &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>33</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>22</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>16</strong> &#x000b1; 6.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>4.2</strong> &#x000b1; 2.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>160</strong> &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>44</strong> &#x000b1; 8.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>31</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.9</strong> &#x000b1; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>32</strong> &#x000b1; 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>36</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B2</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">CH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327239040"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0023.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0023.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0023.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412327239040"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.5</strong> &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>93</strong> &#x000b1; 18</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.1</strong> &#x000b1; 0.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>43</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.4</strong> &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>172</strong> &#x000b1; 26</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>23</strong> &#x000b1; 20</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>28</strong> &#x000b1; 4.3</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B3</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412360665072"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0024.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0024.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0024.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412360665072"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d. &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d. &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.2</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.7</strong> &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>116</strong> &#x000b1;7.4</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.1</strong> &#x000b1; n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B4</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412323021296"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0025.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0025.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0025.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412323021296"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>23</strong> &#x000b1; 8.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>41</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>16</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>40</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>29</strong> &#x000b1; 8.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>144</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B5</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412325308096"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0026.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0026.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0026.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412325308096"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>26</strong> &#x000b1; 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>17</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>31</strong> &#x000b1; 1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.4</strong> &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>128</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>17</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>30</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B6</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412321519600"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0027.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0027.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0027.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412321519600"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>35</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1">29 &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>33</strong> &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>130</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B7</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327582288"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0028.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0028.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0028.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412327582288"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>32</strong> &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>29</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.4</strong> &#x000b1; 3.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>140</strong> &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>33</strong> &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">29 &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>B8</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">Cl</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327259984"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0029.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0029.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0029.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412327259984"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>14</strong> &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>35</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>1.0</strong> &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>121</strong> &#x000b1; 9.2</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td colspan="22" align="center" valign="middle" rowspan="1"><hr /></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C1</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412364202512"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0030.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0030.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0030.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412364202512"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.9</strong> &#x000b1; 1.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>57</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>8.3</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>27</strong> &#x000b1; 1.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.8</strong> &#x000b1; 2.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>132</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>54</strong> &#x000b1; 4.3</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C2</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412326864992"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0031.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0031.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0031.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412326864992"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.4</strong> &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 5.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>27</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>17</strong> &#x000b1; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.7</strong> &#x000b1; 2.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>131</strong> &#x000b1; 9.8</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>31</strong> &#x000b1; 9.2</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C3</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412325201776"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0032.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0032.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0032.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412325201776"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.9</strong> &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>56</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>13</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>39</strong> &#x000b1; 16</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 0.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.5</strong> &#x000b1; 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>151</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>29</strong> &#x000b1; 8.6</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C4</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412320841056"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0033.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0033.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0033.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412320841056"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.2</strong> &#x000b1; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>76</strong> &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>12</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>38</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>27</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 1.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>4.4</strong> &#x000b1; 1.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>147</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>52</strong> &#x000b1; 2.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>46</strong> &#x000b1; 5.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C5</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412322178048"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0034.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0034.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0034.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412322178048"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>71</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; 17</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>27</strong> &#x000b1; 7.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>36</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>27</strong> &#x000b1; 7.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>23</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>165</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>22</strong> &#x000b1; 20</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>35</strong> &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>41</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C6</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412321864928"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0035.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0035.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0035.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412321864928"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.4</strong> &#x000b1; 2.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>62</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>21</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>36</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>45</strong> &#x000b1; 8.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>17</strong> &#x000b1; 2.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>11</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>152</strong> &#x000b1; 20</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>32</strong> &#x000b1; 10</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C7</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412325250400"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0036.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0036.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0036.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412325250400"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>8.2</strong> &#x000b1; 2.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>45</strong> &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>16</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>36</strong> &#x000b1; 20</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.2</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.0</strong> &#x000b1; 2.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>141</strong> &#x000b1; 9.0</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 8.3</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C8</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412326028192"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0037.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0037.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0037.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412326028192"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>17</strong> &#x000b1; 8.7</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>39</strong> &#x000b1; 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>14</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>44</strong> &#x000b1; 8.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.5</strong> &#x000b1; 2.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>135</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C9</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412325995952"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0038.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0038.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0038.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412325995952"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>7.3</strong> &#x000b1; 3.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>67</strong> &#x000b1; 8.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>11</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 17</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>23</strong> &#x000b1; 3.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.1</strong> &#x000b1; 2.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>140</strong> &#x000b1; 9.7</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.4</strong> &#x000b1; 0.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>51</strong> &#x000b1; 7.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>39</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C10</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412322121488"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0039.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0039.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0039.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412322121488"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.4</strong> &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>84</strong> &#x000b1; 9.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.6</strong> &#x000b1; 4.8</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>48</strong> &#x000b1; 17</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>28</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>15</strong> &#x000b1; 3.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3.7</strong> &#x000b1; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>155</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>2.6</strong> &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>53</strong> &#x000b1; 16</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C11</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">OCH<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412321978768"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0040.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0040.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0040.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412321978768"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.4</strong> &#x000b1; 2.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>70</strong> &#x000b1; 4.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>33</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>25</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>9.9</strong> &#x000b1; 2.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.2</strong> &#x000b1; 2.9</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>159</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>33</strong> &#x000b1; 17</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>46</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>39</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.8</strong> &#x000b1; n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C12</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327162128"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0041.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0041.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0041.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412327162128"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>21</strong> &#x000b1; 5.0</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>47</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>20</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>6.9</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>22</strong> &#x000b1; 17</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>167</strong> &#x000b1; 13</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>35</strong> &#x000b1; 21</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>34</strong> &#x000b1; n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>C13</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">H</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327129888"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0042.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-t0042.jpg" src="/pmc/articles/PMC8146373/bin/nihms-1674663-t0042.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140412327129888"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>5.7</strong> &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>45</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>19</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 3.3</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>113</strong> &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>18</strong> &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>37</strong> &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>BETP</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>24</strong> &#x000b1; 12</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>51</strong> &#x000b1; 25</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>31</strong> &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>42</strong> &#x000b1; 2.0</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>17</strong> &#x000b1; 14</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>152</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.8</strong> &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>76</strong> &#x000b1; 22</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.8</strong> &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>91</strong> &#x000b1; 16</td></tr><tr><td colspan="22" align="center" valign="middle" rowspan="1"><hr /></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>Sec-FL [pM]</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.5</strong> &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>117</strong> &#x000b1; 11</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.4</strong> &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>104</strong> &#x000b1; 4.4</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.5</strong> &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>113</strong> &#x000b1; 8.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>3766</strong> &#x000b1;2300</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>104</strong> &#x000b1; 9.0</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>GLP-1 [pM]</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.6</strong> &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>121</strong> &#x000b1; 5.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>0.6</strong> &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>119</strong> &#x000b1; 6.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><strong>AVP [pM]</strong></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>1.3</strong> &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1"><strong>109</strong> &#x000b1; 2.5</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140412327893424"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T1/?report=objectonly">Open in a separate window</a></div></div><p id="P29">Encouraged by the promising profiles of original hits, we expanded
structural diversity within scaffolds by obtaining commercially available
analogs (analog-by-catalog, ABC) for each scaffold to further validate and
optimize putative leads. In total, we acquired 33 compounds, 12 of which are
structural analogs of 2-sulfonyl pyrimidines, 8 analogs for 2-mercapto
pyrimidines and 13 compounds incorporating 2-aminopyrimdine scaffold. All
molecules were subjected to SCTR-specific cAMP and binding assays and, in
parallel, to a screen against AVP2Rs to exclude undesirable cross-selectivity.
For PAM screening purposes and high-throughput detection of structure-activity
relationships (SARs), we established and performed cAMP accumulation assays
using a fixed concentration (EC<sub>10</sub>-EC<sub>20</sub>) of peptide
ligand(s) to achieve a basal orthosteric stimulator response necessary to
visualize PAM activity [<a href="#R30" rid="R30" class=" bibr popnode">30</a>]. We deployed
the natural full-length ligands secretin and AVP (arginine vasopressin) for
basal activation of SCTR and AVP2Rs, respectively. In addition, we tested the
set of structural analogs in SCTR cAMP assays stimulated with 3-peptide mix
(3-pep mix), which comprises full-length secretin (Sec-FL) in combination with
its C- terminally truncated, low-potent but fully efficacious analog secretin
1&#x02013;23 (Sec(1&#x02013;23)) and N-terminally cleaved, partially active
secretin 3&#x02013;27 (Sec(3&#x02013;27)). In a previous study [<a href="#R30" rid="R30" class=" bibr popnode">30</a>], the application of 3-pep mix resulted not only
in substantially increased assay sensitivity, but also allowed the detection of
probe-dependent hits. Since PAMs may exert intrinsic activity, we additionally
conducted SCTR cAMP agonist assays in the absence of peptide ligands (SCTR
agonist). To further profile and validate structural analogs with respect to
target engagement and MOA, we performed TR-FRET based receptor binding assays by
monitoring the effect of compounds on the interaction of N-terminal SNAP-tagged
and Lumi-4 terbium cryptate-labeled SNAP-SCTRs with Fluo-Sec, a version of
secretin linked to a C-terminal fluorescein molecule. <a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> (Column 1&#x02013;6) summarizes potencies and
efficacies of 33 structural analogs determined by dose-response studies in the
five described assay formats. 28 of 33 compounds demonstrated significant
activity in SCTR PAM (3-pep mix) assay with negligible intrinsic agonist
activity nor showing substantial off-target effects on AVP2Rs. Since all
compounds, especially those with scaffold B and C, showed similar overall
profiles but lower responses in full-length secretin (Sec-FL) stimulated SCTR
PAM assays, we decided to concentrate on 3-pep mix assays for characterizing PAM
activities described below. Consistent with the functional data, all but 6
analogs were able to significantly increase Fluo-Sec binding to SNAP-SCTRs.</p><p id="P30">Within the group of 2-sulfonyl pyrimidines, compounds <strong>A1</strong>,
<strong>A2</strong>, <strong>A4</strong>, <strong>A5</strong>, <strong>A6</strong>,
<strong>A7</strong> and <strong>A8</strong> share 3, 4-dimethoxy substituents at the
phenyl (ring A) connected to the pyrimidine, but carry different substitution
patterns on aryl function (Ar) that is connected to the sulfonyl pyrimidine
(ring B) by a butanamide. Although having a similar activity profile overall,
the substituents at the aniline (Ar) had an impact on PAM activity at SCTRs.
<strong>A1</strong>, possessing a 2, 4-fluoro substitution at ring C, exerted
PAM activity with a maximal efficacy of around 60% on SCTRs. Interestingly, the
3-chloro-4-fluoro analog <strong>A4</strong> as well as the 2-methoxy-4-chloro
variant <strong>A7</strong> lost SCTR PAM activity (E<sub>max</sub> ~30&#x02013;40%),
whereas <strong>A6</strong> (2-fluoro analog) and <strong>A8</strong>
(2-bromo-4,6-fluoro, substitution) gained PAM efficacy for SCTRs
(EC<sub>50</sub> 8&#x02013;13 &#x003bc;M, E<sub>max</sub> 63&#x02013;77%).
Compound <strong>A3</strong>, like <strong>A1</strong> holding 2,4-fluoro substitutions
at the aniline (Ar) but a 2-methoxy group at ring A, demonstrated moderate PAM
activity on SCTRs (EC<sub>50</sub> 7.0 &#x003bc;M, E<sub>max</sub> 40%). To
evaluate the relevance of the aryl (Ar) function, we tested <strong>A9</strong>,
<strong>A10</strong> and <strong>A12,</strong> which share the 2-methoxy
substitution at ring A but possess either no third aromatic moiety
(<strong>A10</strong>, <strong>A12</strong>) or a fourth aromatic group
(<strong>A9</strong>). <strong>A10</strong> whose sulfonyl group is attached to
butyric acid, displayed no significant activity in all assays, while
2-methylsulfonyl pyrimidine <strong>A12</strong> showed a low-potent effect on SCTRs
(EC<sub>50</sub> 18 &#x003bc;M, E<sub>max</sub> 49%). Strikingly, despite
showing substantial functional responses, <strong>A12</strong> did not enhance
Fluo-Sec binding to SNAP-SCTRs. <strong>A9</strong>, which contains a
1-[(4-methylphenyl)methyl]3-amino-1H-pyrazole instead of a halogen-substituted
aniline, suffered from a loss of efficacy (E<sub>max</sub> 42%) but was the most
potent compound in this series (EC<sub>50</sub> ~3 &#x003bc;M) in SCTR PAM mode.
We also tested a 4-fluorophenyl-difluoromethyl pyrimidine analog
(<strong>A11</strong>) that had no effect on SCTR binding or activation.</p><p id="P31">2-Mercapto pyrimidines (<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>,
Column 1&#x02013;6) appear as reduced analogs of 2-sulfonyl pyrimidines due to
the substitution of the sulfonyl into a thioether function. Other
characteristics of group B analogs include a shorter linker missing one to two
carbon atoms and a methylated amide function for select compounds. Compound
<strong>B1</strong>, the original hit, possesses as <strong>A1</strong> 3,
4-dimethoxy substituents at ring A but a methylated acetamide linker connecting
the 2-mercapto pyrimidine core to an unsubstituted phenyl (Ar). In SCTR PAM
assay, <strong>B1</strong> demonstrated moderate activity (EC<sub>50</sub> 3.6
&#x003bc;M, E<sub>max</sub> 47%) and was devoid of significant intrinsic activity
or effects on AVP2Rs. In addition, <strong>B1</strong> substantially increased
Fluo-Sec binding at SNAP-SCTRs (EC<sub>50</sub> 4.2 &#x003bc;M, 60% increase of
binding) [<a href="#R30" rid="R30" class=" bibr popnode">30</a>]. All 7 structural analogs
of the original HTS hit <strong>B1</strong>, demonstrate clean and selective PAM
activity, devoid of significant effects in AVP2R PAM as well as in SCTR agonist
assays. Intriguingly, <strong>B2</strong>, which differs from <strong>B1</strong> by
lacking the 3-methoxy group at ring A, showed the strongest PAM activity toward
SCTRs amongst all 33 analogs with 2.4 &#x003bc;M potency and 93% efficacy in
3-pep mix cAMP assays and a 76 percent increase of Fluo-Sec/SNAP-SCTR complexes
(EC<sub>50</sub> 2.5 &#x003bc;M). In contrast, analog <strong>B3</strong> was
inactive in all assays, probably due to the removal of all substituents at ring
A and/or the missing methyl group at the amide function. Similarly, compound
<strong>B4</strong> whose amide is mono-substituted with a 4-methylpyridine
lacked significant activity in any formats. We wondered if the elongation of the
structure led to attenuated PAM activity. Therefore, we tested additionally a
version of <strong>B2</strong> incorporating a propanamide linker, which is attached
to a 2, 5-difluorophenyl group (<strong>B5</strong>). Even though this modification
resulted in an increase of potency (EC<sub>50</sub> 0.3&#x02013;1.4 &#x003bc;M)
<strong>B5</strong> seemed inferior to <strong>B2</strong> with respect to PAM
efficacy (E<sub>max</sub> ~30%). To explore the influence of substituents on the
third aromatic head (Ar), we evaluated the responses of two analogs of
<strong>B3</strong>, which bear either an indanyl (<strong>B6</strong>) or a 2,
3-chlorophenyl (<strong>B7</strong>) function instead of the plain phenyl group
present at <strong>B3</strong>. Both structural analogs were able to slightly
increase PAM activity at SCTRs (EC<sub>50</sub> 1.6&#x02013;2.9 &#x003bc;M,
E<sub>max</sub> 20&#x02013;32%) compared to <strong>B3</strong>, however, the
indanyl analog <strong>B6</strong> was not able to increase Fluo-Sec binding to
SNAP-SCTRs. Compound <strong>B8</strong>, carrying a 4-chloro substituent at ring A
and a 2-methyl substitution at aniline (Ar), also lacked the ability to modulate
SCTRs.</p><p id="P32">The third set of compounds (<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table
1</span></a>, Column 1&#x02013;6) consisted of structural analogs incorporating
the 4-phenyl-6-trifluoromethyl pyrimidine core with a benzylamine
(<strong>C1</strong>-<strong>12</strong>) or phenethylamine (<strong>C13</strong>)
substitution at position 2. The original HTS hit <strong>C1</strong>, contained a
4-methoxybenzylamine function and, like <strong>A1</strong> and <strong>B1,</strong> 3,
4-dimethoxy groups at ring A. Similar to all structural analogs within group C,
<strong>C1</strong> elevated Fluo-Sec binding to SNAP-SCTRs (EC<sub>50</sub> 2.5
&#x003bc;M, 36% increase of binding), was devoid of off-target effects at AVP2Rs
and hardly displayed intrinsic agonist activity at SCTRs. However,
<strong>C1</strong> demonstrated significant PAM activity with single-digit
micromolar potency and maximal efficacy around 60 percent [<a href="#R30" rid="R30" class=" bibr popnode">30</a>]. We divided 2-amino pyrimidine analogs into five
distinct sets according to their substitution pattern at ring A. The first set
comprising <strong>C1</strong>, <strong>C4</strong>, <strong>C5</strong>, <strong>C9</strong>
and <strong>C10</strong> bears 3, 4-dimethoxy groups at cycle A but differ from
their substitutions at the benzylamine function. Comparing to the original hit
<strong>C1</strong>, the unsubstituted benzylamine analog <strong>C4</strong> gains
PAM effects with respect to SCTR cAMP accumulation (EC<sub>50</sub> 6.2
&#x003bc;M, E<sub>max</sub> 76%) and binding (EC<sub>50</sub> 4.4 &#x003bc;M, 4.7%
increase of binding). Replacement of the phenyl by a 3-pyridine ring
(<strong>C5</strong>) led to a three-fold loss of potency toward SCTRs. The
4-chloro (<strong>C9</strong>) and 4-fluoro (<strong>C10</strong>) analogs demonstrated
significant PAM activity similar to <strong>C4</strong>. The second set of compounds
comprising <strong>C2</strong> and <strong>C3</strong>, that are structural analogs of
<strong>C1</strong> and <strong>C4</strong>, respectively, lacking the 3-methoxy
group at ring A. Interestingly, while maintaining a similar overall profile,
<strong>C2</strong> and <strong>C3</strong> showed slightly lower PAM effects across
receptor functional assays (SCTR PAM E<sub>max</sub> 37&#x02013;56%). Compounds
<strong>C6</strong>, <strong>C7</strong> and <strong>C11</strong> constituted the third
set bearing a methoxy substitution at position 3 of ring A and displayed equally
significant PAM effects as their direct analogs <strong>C3</strong>, <strong>C6</strong>
and <strong>C10</strong>, respectively. Strikingly, <strong>C8</strong> (set 4),
structurally related to <strong>C1</strong> and <strong>C2</strong> due to the
4-methoxybenzylamine function but containing a 2-methoxy substitution at ring A,
suffered from a loss of potency in SCTR PAM assays. The fifth set within
scaffold C comprised analogs <strong>C12</strong> and <strong>C13</strong>, which lack
any substitution at cycle A. To explore the impact of the aromatic benzylamine
moiety, we examined the effects of <strong>C12</strong> whose 2-amino pyrimidine is
connected to an ethyl acetate group. Even though it suffers from lower potencies
(EC<sub>50</sub> 21&#x02013;34 &#x003bc;M) in all formats, <strong>C12</strong>
was able to enhance SCTR activation and binding. We additionally investigated
the influence of an elongation of the linker by testing the 3,4-dimethoxy
phenethylamine analog <strong>C13</strong>, which was demonstrating substantial PAM
activity at SCTRs in functional (EC<sub>50</sub> 5.7 &#x003bc;M, E<sub>max</sub>
45%) but not in binding assays (EC<sub>50</sub> 18 &#x003bc;M, 13% increase of
binding).</p><p id="P33" class="p p-last">For more detailed allosteric activities and MOA studies, we selected two
analogs for each scaffold group (<a href="/pmc/articles/PMC8146373/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>).
To facilitate further SAR conclusions, we focused on structural analogs
displaying moderate to strong PAM effects that differed by a single structural
feature in each scaffold group. According to these selection criteria, we
characterized <strong>A1</strong> and <strong>A2</strong> with distinct substitution
patterns on ring C, <strong>B1</strong> and <strong>B2</strong>, which only
differentiate from each other by a methoxy group at position 3 of ring A, as
well as <strong>C4</strong> and <strong>C9</strong> with a plain or 4-chloro substituted
benzylamine function (ring C), respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC8146373/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412326946848"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412326946848"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Modulator titration reveals allosteric activity profiles dependent on
distinct orthosteric ligands:</strong><p id="P59">cAMP dose-response curves of (A) Sec-FL, (B) Sec(1&#x02013;23), (C)
Sec(3&#x02013;27) on SCTRs treated with DMSO or six increasing concentrations of
compounds (from left to right: <strong>A1</strong>, <strong>A2</strong>,
<strong>B1</strong>, <strong>B2</strong>, <strong>C4</strong> and <strong>C9</strong>) ranging
from 0.8 to 25 &#x003bc;M; TR-FRET ratios converted to cAMP concentrations and
normalized to corresponding orthosteric ligand; allosteric activity parameters
K<sub>B</sub>, &#x003b1; and &#x003b2; were determined using the complete
operational model of allosterism in GraphPad Prism; experiments were performed
in duplicate in three independent experiments and data points are shown as mean
&#x000b1; SEM. For select compound concentrations only below error bars are shown
for illustrative purposes.</p></div></div></div></div><div id="S25" class="sec"><h3 id="S25title">3.2. Cooperativity factors reveal structure-related probe dependencies</h3><p id="P34" class="p p-first-last">To evaluate allosteric activity parameters of putative PAMs, we
performed allosteric modulator titrations on orthosteric peptide ligand
dose-response curves in cAMP assays. Being aware of allosteric modulator probe
dependency [<a href="#R10" rid="R10" class=" bibr popnode">10</a>, <a href="#R31" rid="R31" class=" bibr popnode">31</a>], the phenomenon that allosteric modulators exert
distinct effects depending on the orthosteric stimulator probe present, we
evaluated individually the allosteric activities toward full agonists Sec-FL and
Sec(1&#x02013;23) or the partial agonist Sec(3&#x02013;27), the N-terminally
truncated secretin analog. Allosteric activity parameters, which characterize
the nature and power of an allosteric modulator, consist of the equilibrium
dissociation constant K<sub>B</sub> and cooperativity factors on ligand-receptor
complexes &#x003b1; and &#x003b2;, whereby &#x003b1; describes the allosteric
modulation on ligand potency/binding affinity and &#x003b2; delineates
cooperative effects on ligand efficacy [<a href="#R31" rid="R31" class=" bibr popnode">31</a>]. Dose-response curves of peptide ligands were recorded with five
increasing doses of test compound (<a href="/pmc/articles/PMC8146373/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>,
800 nM to 25 &#x003bc;M) and allosteric activity parameters were determined using
the complete operational model of allosterism [<a href="#R31" rid="R31" class=" bibr popnode">31</a>] on the concentrations of cAMP formed during simultaneous
compound and ligand treatment. The investigations on 2-sulfonyl pyrimidines
<strong>A1</strong> and <strong>A2</strong> resulted in a very similar profile. Both
test molecules demonstrated greater cooperativity toward secretin peptide
efficacies than ligand potencies, while their affinities ranged between 0.4 and
6.4 &#x003bc;M. Overall, they appeared to have similar effects on Sec-FL and its
truncated analogs. Strikingly, the titrations of structural analogs
<strong>B1</strong> and <strong>B2</strong>, whose key distinction is the presence
or absence of a 3-methoxy group at ring A, respectively, revealed substantially
different allosteric activity profiles. On SCTR-overexpressing cells,
<strong>B1</strong> demonstrated positive cooperativity in combination with
Sec-FL and Sec(1&#x02013;23) but negative cooperativity with Sec(3&#x02013;27)
with respect to ligand efficacy (&#x003b2; 0.3). <strong>B2</strong> discriminated
even more, displaying strong positive modulation of potency but not efficacy of
Sec(1&#x02013;23) (&#x003b1; 36; &#x003b2; 0.8), while also demonstrating strong
potentiation of Sec(3&#x02013;27) efficacy (&#x003b1; 6; &#x003b2; 30). In
addition, we studied allosteric effects of 2-amino pyrimidine analogs
<strong>C4</strong> (-H) and <strong>C9</strong> (-Cl). In general, we determined
relatively similar PAM profiles for both compounds. With dissociation constants
K<sub>B</sub> in the single to double-digit micro molar range, 2-amino
pyrimidines exerted significant cooperativities toward secretin peptides with
maximal positive modulation for Sec(3&#x02013;27) (&#x003b1; 5&#x02013;7; &#x003b2;
8&#x02013;9).</p></div><div id="S26" class="sec"><h3 id="S26title">3.3. B2 substantially decelerates secretin dissociation on SNAP-SCTRs</h3><p id="P35" class="p p-first">To further decipher the MOA of test compounds on SCTRs, we performed
dissociation binding experiments [<a href="#R36" rid="R36" class=" bibr popnode">36</a>].
One characteristic of class B GPCR activation is the two-domain binding model of
its natural peptide ligands [<a href="#R2" rid="R2" class=" bibr popnode">2</a>], i.e. the
C-terminal portion of full-length secretin binds with moderate to high affinity
to the extracellular N-domain (ECD) of the receptor while the N-terminal end of
secretin interacts with the helical core bundle (J-domain) with much lower
affinity, inducing conformational arrangements that result in the activation of
intracellular signaling pathways predominantly through G&#x003b1;s proteins.
Hence, peptide concentration and affinity to the N-domain define receptor
occupancy whereas binding to both domains is dependent on receptor conformations
mainly regulated by G-protein coupling as reported for class A GPCRs [<a href="#R37" rid="R37" class=" bibr popnode">37</a>], which leads to higher agonist
affinities in the G protein-bound state. To facilitate interpretation of data,
we added GTP&#x003b3;S to the dissociation buffer, which is described to shift
the equilibrium of receptors into the G protein-unbound state and thereby
attenuates J-domain binding [<a href="#R38" rid="R38" class=" bibr popnode">38</a>]. Thus,
after inducing dissociation, the majority of peptide ligand binds to only one
site, the N-domain of receptors, which in addition leads to an elevated off-rate
for Fluo-Sec (<a href="/pmc/articles/PMC8146373/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC8146373/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412326938864"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412326938864"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Analog B2 substantially prolongs Fluo-Sec residence time on
SNAP-SCTRs:</strong><p id="P60">Effects of DMSO, 12.5 &#x003bc;M of (A) 2-sulfonyl pyrimidines
<strong>A1</strong> (dark green), <strong>A2</strong> (light green), (B) 2-mercapto
pyrimidines <strong>B1</strong> (light blue), <strong>B2</strong> (dark blue), (C)
2-amino pyrimidines <strong>C4</strong> (light red), <strong>C9</strong> (dark red) or
(B) 3.1 or 6.3 &#x003bc;M <strong>B2</strong> (dotted lines in blue shades) on
dissociation half-lives t<sub>1/2</sub> of Fluo-Sec from SNAP-SCTR HEK-293 cell
membranes induced by addition of an excess Sec-FL. LanthaScreen ratios
normalized to Fluo-Sec bound at time 0; dissociation half-lives
(t<sub>1/2</sub>) determined applying <em>Dissociation &#x02013; One phase
exponential decay</em>-equation in GraphPad Prism 8.4.0; experiments
performed in triplicate in at least three independent experiments; data points
shown as mean &#x000b1; SD. Statistical significance of rate constant K changes
compared to DMSO determined using GraphPad Prism&#x02019;s unpaired t-test
corrected with Holm-Sidak method, &#x003b1; = 0.01; (A) not significant; (B, C)
significant (p &#x0003c; 0.01).</p></div></div></div><p id="P36" class="p p-last">We investigated the impact of putative PAMs on Fluo-Sec dissociation
induced by excess concentration of Sec-FL from SNAP-SCTR expressing HEK-293 cell
membranes by adding 12.5 &#x003bc;M of test compound or DMSO to the dissociation
buffer and recording dissociation binding curves to determine residence time
half-lives (t<sub>1/2</sub> [min]). 2-Sulfonyl pyrimidines <strong>A1</strong>
[<a href="#R30" rid="R30" class=" bibr popnode">30</a>] and <strong>A2</strong> slightly
decelerated Fluo-Sec dissociation compared to control wells (t<sub>1/2</sub> 14
min) with half-lives between 15 and 16 min (<a href="/pmc/articles/PMC8146373/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig.
2A</span></a>). The changes in rate constants K were determined to be not
statistically significant. Addition of <strong>B1</strong> [<a href="#R30" rid="R30" class=" bibr popnode">30</a>], <strong>C4</strong> or <strong>C9</strong> resulted in a
more significant effect, reducing dissociation rates of Fluo-Sec to half-lives
between 25 and 30 min (<a href="/pmc/articles/PMC8146373/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>, <a href="/pmc/articles/PMC8146373/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,C).</span></span><span>C</span></a>). Even more pronounced was the impact of
structural analog <strong>B2</strong> prolonging receptor residence time by 13-fold
with a dissociation half-life of 177 min (<a href="/pmc/articles/PMC8146373/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig.
2B</span></a>). To explore the strength of this interaction in more detail, we
determined half-lives at 3.1 &#x003bc;M (58 min) and 6.3 &#x003bc;M (108 min) of
<strong>B2</strong>, which confirmed that <strong>B2</strong> significantly slows
down Fluo-Sec dissociation in a dose-dependent manner.</p></div><div id="S27" class="sec"><h3 id="S27title">3.4. SCTR PAMs potentiate signaling in endogenously receptor-bearing NG108
cells</h3><p id="P37" class="p p-first-last">Since receptor overexpressing cell lines and membranes applied in
selectivity and allosteric activity studies, may display overly amplified or
distorted signaling, we investigated the response of test compounds in the
neuroglioma hybrid cell line NG108(&#x02212;15), which was created by fusion of
mouse neuroblastoma with rat glioma cells (ATCC) and has been described to
endogenously express SCTRs [<a href="#R39" rid="R39" class=" bibr popnode">39</a>]. To
determine PAM activity, we incubated 25 &#x003bc;M of test compound with
increasing concentrations of peptide ligands and recorded corresponding changes
in cAMP accumulation. <a href="/pmc/articles/PMC8146373/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a> illustrates
the modulation of 2-sulfonyl pyrimidines <strong>A1</strong> and <strong>A2</strong> on
Sec-FL, Sec(1&#x02013;23) and Sec(3&#x02013;27). In this format, the effects of
<strong>A1</strong> and <strong>A2</strong> appeared to be mainly based on intrinsic
agonist activity elevating basal activity by 30 to 40 percent. Cooperative
effects of group A analogs toward Sec-FL and Sec(1&#x02013;23) were minor,
detected as around two-fold improved potencies and a 20 percent gain of
efficacies. The effects of 2-mercapto pyrimidines in NG108 cells are depicted in
<a href="/pmc/articles/PMC8146373/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figures 3B</span></a>. Analog <strong>B1</strong>
displayed an around 20% elevation of basal activity and showed positive
cooperativity toward Sec-FL and Sec(1&#x02013;23) potencies, whereas the
4-methoxy analog <strong>B2,</strong> even though exerting similar positive effects
on full agonists (3&#x02013;7-fold leftward shift), did not show signs of
intrinsic agonist activity. In addition, <strong>B2</strong> was able to convert the
inactive Sec(3&#x02013;27) into a partial agonist with 20% efficacy in NG108
cells. In contrast, 2-amino pyrimidines <strong>C4</strong> and <strong>C9</strong>
(<a href="/pmc/articles/PMC8146373/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3C</span></a>) exhibited negligible effects
in this cell model, displaying 2&#x02013;3-fold improved potencies in combination
with Sec-FL and Sec(1&#x02013;23) and having no effect on Sec(3&#x02013;27).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC8146373/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412326932736"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412326932736"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>SCTR modulators exert PAM activity in NG108&#x02013;15 cell line:</strong><p id="P61">cAMP dose-response of (A, B, C, left to right) Sec-FL, Sec(1&#x02013;23)
and Sec(3&#x02013;27) in NG108 cells treated with DMSO (black), 25 &#x003bc;M of
(A) 2-sulfonyl pyrimidines <strong>A1</strong> (dark green), <strong>A2</strong> (light
green), (B) 2-mercapto pyrimidines <strong>B1</strong> (light blue), <strong>B2</strong>
(dark blue) or (C) 2-amino pyrimidines <strong>C4</strong> (light red),
<strong>C9</strong> (dark red); TR-FRET ratios resulting from cAMP accumulation
normalized to Sec-FL; graphs plotted using GraphPad Prism; experiments performed
in duplicates in at least three independent experiments; data points shown as
mean &#x000b1; SEM. Statistical significance determined using GraphPad
Prism&#x02019;s unpaired t-test corrected with Holm-Sidak method.</p></div></div></div></div><div id="S28" class="sec"><h3 id="S28title">3.5. Structural similarity to GLP-1R small molecule agonists discloses
GLP-1R-modulation by SCTR PAMs</h3><p id="P38" class="p p-first">During our SAR studies on SCTR PAMs, we discovered that 2-sulfonyl
pyrimidine moieties had been described to exert electrophilic reactivity and
possess mild alkylating properties [<a href="#R40" rid="R40" class=" bibr popnode">40</a>,
<a href="#R41" rid="R41" class=" bibr popnode">41</a>]. Beyond that, we found clear
structural similarity to described GLP-1R agonists/PAMs <strong>Compound A</strong>
[<a href="#R12" rid="R12" class=" bibr popnode">12</a>] and <strong>BETP</strong> [<a href="#R7" rid="R7" class=" bibr popnode">7</a>] (<a href="/pmc/articles/PMC8146373/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig.
4A</span></a> 1.), referring to the 4-phenyl-6-trifluoromethyl pyrimidine core
(ring A and B) incorporated in <strong>Compound A</strong>/<strong>BETP</strong>
structures that is consistently present across all three SCTR PAM scaffolds
(<a href="/pmc/articles/PMC8146373/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a> 2.&#x02212;4.). To investigate
whether our newly identified SCTR PAMs also exhibit effects at GLP-1Rs, we
performed cAMP assays using GLP-1R-overexpressing HEK-293T cells in agonist and
PAM mode, performed in the absence or in the presence of EC<sub>20</sub>
concentration of GLP-1, respectively (<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table
1</span></a>, Column 7&#x02013;8). For comparison of our 33 analogs with a
thoroughly characterized GLP-1R ago-PAM, <strong>BETP</strong> was included as
reference to all performed assays (<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table
1</span></a>, Column 1&#x02013;8). As expected, <strong>BETP</strong> exerted strong
PAM and agonist activity toward GLP-1Rs (EC<sub>50</sub> 0.8 &#x003bc;M,
E<sub>max</sub> 76&#x02013;91%). Even though PAM activity at SCTRs has never
been reported for <strong>BETP</strong>, it was also able to positively modulate
SCTR binding and activation (SCTR PAM E<sub>max</sub> 51 %). Nevertheless,
<strong>BETP</strong> potency toward SCTRs was significantly lower (SCTR PAM
EC<sub>50</sub> 24 &#x003bc;M) resulting in a 30-fold selectivity toward
GLP-1Rs. Within our group of SCTR PAMs, only scaffold A analogs exerted
significant intrinsic activities (<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table
1</span></a>, Column 8, GLP-1R agonist). However, in GLP-1R PAM format not only
2-sulfonyl pyrimidines but also 2-amino pyrimidines and select analogs of
2-mercapto pyrimidines were able to substantially increase GLP-1 stimulated cAMP
accumulation in HEK-293T-GLP-1R cells (<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table
1</span></a>, Column 7, GLP-1R PAM). To assess overall receptor preferences, we
depicted the maximal efficacy (E<sub>max</sub> [%]) of test compounds with
respect to SCTR PAM (3-pep mix) activity in correlation to their PAM effects on
GLP-1Rs in a scatterplot (<a href="/pmc/articles/PMC8146373/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4B</span></a>). Within
the group of 2-sulfonyl pyrimidines, <strong>A3</strong> (2-methoxy analog of
<strong>A1)</strong>, the 3-chloro-4-fluoro analog <strong>A4</strong>,
2-methoxy-4-chloro variant <strong>A7</strong>, <strong>A11</strong>
(4-fluorophenyl-difluoromethyl pyrimidine analog of GLP-1R ago-PAM
<strong>Compound A</strong>) and the 2-methylsulfonyl pyrimidine
<strong>A12</strong> demonstrated an overall selectivity trend toward GLP-1Rs.
Interestingly, group A analogs lacking the third aromatic moiety (Ar) seemed to
generally favor GLP-1Rs, whereas both, substitution patterns at ring A and at
the aniline Ar, influenced receptor selectivity profiles.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC8146373/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327189888"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412327189888"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Three related scaffolds demonstrate structural and functional similarity to
GLP-1R ago-PAMs Compound A and BETP:</strong><p id="P62">(A) Molecular structures of 1. established GLP-1R PAMs Compound A and
BETP, 2. Group A 2-sulfonyl pyrimidines <strong>A1</strong>, <strong>A2</strong> and
<strong>A3</strong>, 3. Group B 2-mercapto pyrimidines <strong>B1</strong> and
<strong>B2</strong>, 4. Group C 2-amino pyrimidines <strong>C4</strong> and
<strong>C9</strong>. (B) Scatterplot depicting % maximal efficacy
(E<sub>max</sub>) in SCTR PAM (3-pep mix) cAMP assays (x-axis) in
correlation to % E<sub>max</sub> in GLP-1R PAM mode (y-axis), color code
according to scaffold sets A (blue), B (green), C (red) and positive controls
Sec-FL, GLP-1 and BETP (orange); scatterplot created using TIBCO Spotfire.</p></div></div></div><p id="P39" class="p p-last">In contrast, 2-mercapto pyrimidines (group B) as well as 2-amino
pyrimidines (group C) appeared to favor SCTRs, even though select analogs showed
substantial effects in cAMP GLP-1R PAM assays. Of the six analogs we had
investigated in more detail, we found five (<strong>A1</strong>, <strong>A2</strong>,
<strong>B1</strong>, <strong>C4</strong> and <strong>C9</strong>) displaying a balanced
profile. However, compound <strong>B2</strong>, which differs from <strong>B1</strong>
by missing the 3-methoxy group at ring A, strongly preferred modulating SCTRs by
displaying only moderate PAM activity at GLP-1Rs.</p></div><div id="S29" class="sec"><h3 id="S29title">3.6. SCTR - GLP-1R selectivity profiles considering probe dependencies and GLP-1R
cooperativity factors</h3><p id="P40" class="p p-first">Although initial screens against SCTRs and GLP-1Rs indicated certain
compound selectivity profiles, we were concerned that the use of different
orthosteric stimulator probes could have had impacted receptor preferences. To
investigate GLP-1R effects in more detail, we performed MOA studies with the
same six analogs studied in SCTR experiments. Moreover, to determine binding
affinities and power of allosteric modulators, the evaluation of allosteric
activity parameters against GLP-1Rs is obligatory. Since <strong>BETP</strong> was
shown to have a much greater effect on GLP-1(9&#x02013;36) [<a href="#R12" rid="R12" class=" bibr popnode">12</a>, <a href="#R20" rid="R20" class=" bibr popnode">20</a>], the
DPP4 (dipeptidyl-peptidase-4) cleavage product of GLP-1 [<a href="#R42" rid="R42" class=" bibr popnode">42</a>], than on the full-length peptide GLP-1, we
additionally included GLP-1(9&#x02013;36) in all further studies on GLP-1Rs. As
illustrated in <a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5A</span></a>&#x02013;<a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>B</span></a>, <strong>BETP</strong> showed mild allosteric
activity on GLP-1-treated GLP-1Rs with a dissociation constant K<sub>B</sub> of
3 &#x003bc;M and &#x003b1;/&#x003b2; values between 1 and 3, while in combination
with GLP-1(9&#x02013;36) <strong>BETP</strong> significantly enhanced both potency
(&#x003b1; 137) and efficacy (&#x003b2; 5.5), as illustrated in <a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5A</span></a>&#x02013;<a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>B</span></a>, which is in alignment with previous studies and thereby validated
our approach [<a href="#R20" rid="R20" class=" bibr popnode">20</a>]. Of note, the highest
concentration of <strong>BETP</strong> equal 25 &#x003bc;M was excluded from analysis
as it led to an inversion of its PAM activity. 2-sulfonyl pyrimidines
<strong>A1</strong> and <strong>A2</strong> demonstrated similar profiles with
slightly weaker responses. We observed for <strong>A1</strong> 15&#x02013;200-fold
reduced affinities, compared to its SCTR profile, but substantially increased
cooperative effects on GLP-1(9&#x02013;36) ligand potency (&#x003b1; 247). We
recorded similar overall PAM effects for <strong>A2</strong>, even though its
K<sub>B</sub> and &#x003b1; values remained in a 10-fold lower range
(K<sub>B</sub> 1.5&#x02013;8 &#x003bc;M; &#x003b1; (GLP-1(9&#x02013;36)) 21).
These discrepancies might be due to the electrophilic nature of 2-sulfonyl
pyrimidines, which could interfere with the calculation of equilibrium
dissociation constants and associated factors as allosteric pharmacology models
do not account for covalent binding principles [<a href="#R19" rid="R19" class=" bibr popnode">19</a>, <a href="#R43" rid="R43" class=" bibr popnode">43</a>]. We further studied
the effects of structural analogs <strong>B1</strong> and <strong>B2</strong>, whose key
distinction is the presence or absence of a 3-methoxy group at ring A. Both
analogs showed weak PAM effects on GLP-1 against GLP-1Rs. Interestingly, 3,
4-methoxy analog <strong>B1</strong> was able to substantially increase potency and
efficacy of the N-terminally truncated analog GLP-1(9&#x02013;36) (&#x003b1; 3.5;
&#x003b2; 4.5) whereas 4-methoxy variant <strong>B2</strong> only displayed minor PAM
effects (&#x003b1; 2.9; &#x003b2; 1). In contrast, 2-amino pyrimidine analogs
<strong>C4</strong> (-H) and <strong>C9</strong> (-Cl) displayed negligible
cooperativity on GLP-1(9&#x02013;36)-treated GLP-1R-overexpressing cells while
significantly modulating the full-length peptide GLP-1 in a positive way
(&#x003b1; 3&#x02013;5; &#x003b2; 2).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327182176"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412327182176"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Cooperativity factors reveal distinct selectivity profiles toward
SCTRs/GLP-1R and full-length/truncated peptides:</strong><p id="P63">cAMP dose-response curves of (A) GLP-1 or (B) GLP-1(9&#x02013;36) on
GLP-1Rs treated with DMSO or six increasing concentrations of compounds (from
left to right: <strong>BETP</strong>, <strong>A1</strong>, <strong>A2</strong>,
<strong>B1</strong>, <strong>B2</strong>, <strong>C4</strong> and <strong>C9</strong>)
ranging from 0.8 to 25 &#x003bc;M; (C) Modulator titration of BETP on
SCTR-stimulated cAMP accumulation by (left to right) Sec-FL, Sec(1&#x02013;23) or
Sec(&#x02212;27); TR-FRET ratios converted to cAMP concentrations and normalized
to corresponding orthosteric ligand; allosteric activity parameters
K<sub>B</sub>, &#x003b1; and &#x003b2; were determined using the complete
operational model of allosterism in GraphPad Prism; experiments were performed
in duplicate in three independent experiments and data points are shown as mean
&#x000b1; SEM. For select compound concentrations only below error bars are shown
for illustrative purposes. (D) Compound selectivity toward GLP-1Rs vs SCTRs
determined as &#x00394; log (&#x003b1;&#x003b2;) (SCTR log (&#x003b1;&#x003b2;)
&#x02013; GLP-1R log (&#x003b1;&#x003b2;)) stimulated with either full-length
(solid black) or truncated (white/black stripes) peptide agonists; (E) probe
dependency toward full-length (FL) vs truncated (TR) peptide ligands determined
as &#x00394; log (&#x003b1;&#x003b2;) (TR log (&#x003b1;&#x003b2;) &#x02013; FL log
(&#x003b1;&#x003b2;)) stimulating either SCTRs (black, white dots) or GLP-1Rs
(white, vertical stripes).</p></div></div></div><p id="P41" class="p p-last">We further assessed allosteric activity data of <strong>BETP</strong>
against SCTRs (<a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5C</span></a>). The GLP-1R ago-PAM
<strong>BETP</strong> was able to slightly shift the responses of secretin
peptides displaying the lowest effects in combination with C-terminally
truncated analog Sec(1&#x02013;23). For better comparison of cooperative
strengths and selectivity profiles, we determined the difference between
logarithmic cooperativity factors &#x00394; log (&#x003b1;&#x003b2;) (<a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5D</span></a>). To match results for both
receptors, we concentrated on full-length peptides Sec-FL and GLP-1 as well as
N-terminally truncated (TR) analogs Sec(3&#x02013;27) and GLP-1(9&#x02013;36). For
evaluation of receptor selectivity (<a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig.
5D</span></a>), we depicted &#x00394; log (&#x003b1;&#x003b2;) of full-length peptides
(Sec-FL minus GLP-1) or their truncated analogs (Sec(3&#x02013;27) minus
GLP-1(9&#x02013;36)). To describe probe dependencies within SCTRs or GLP-1Rs
(<a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5E</span></a>), we subtracted log
(&#x003b1;&#x003b2;) of full-length peptides from truncated analogs
(Sec(3&#x02013;27) minus Sec-FL; GLP-1(9&#x02013;36) minus GLP-1).
<strong>BETP</strong>, <strong>A2</strong> and <strong>B1</strong> were GLP-1R-selective
by comparing truncated analogs but displayed slight SCTR preference when treated
with full-length peptides. 2-Amino pyrimidines <strong>C4</strong> and
<strong>C9</strong> preferred partial agonist Sec(3&#x02013;27) stimulation on
SCTRs but full agonist GLP-1 treatment on GLP-1Rs. <strong>A1</strong> and
<strong>B2</strong> were solely selective for GLP-1Rs or SCTRs, respectively,
independent of the nature of the orthosteric ligand. Overall, the preferences
for a distinct receptor were more pronounced while stimulated with a truncated
peptide version (<a href="/pmc/articles/PMC8146373/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5E</span></a>).</p></div><div id="S30" class="sec"><h3 id="S30title">3.7. Select analogs enhance cAMP formation and insulin secretion in INS-1 (832/3)
rat insulinoma cells</h3><p id="P42" class="p p-first">To evaluate the response of test compounds in a naturally GLP-1R-bearing
environment, we used INS-1 (832/3) rat insulinoma cells as cell model with
natural GLP-1R expression, which have been used for studies on insulin secretion
and pancreatic islet beta-cell function [<a href="#R34" rid="R34" class=" bibr popnode">34</a>]. Since the response in INS-1 cells upon GLP-1R activation was
hard to detect with the Gs dynamic cAMP kit (Cisbio) that had been used in all
other cAMP assays described in this study, we switched to the LANCE Ultra kit
(PerkinElmer) with higher sensitivity for the detection of cAMP accumulation in
INS-1 cells. We applied otherwise the same conditions as in our studies in
NG108&#x02013;15 cells (25 &#x003bc;M of test compound, peptide ligand titration),
except for <strong>BETP</strong>, which had displayed inverse effects at 25
&#x003bc;M in GLP-1R overexpressing cells. Hence, we reduced its test
concentration to 12.5 &#x003bc;M. <a href="/pmc/articles/PMC8146373/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6A</span></a>
illustrates the effects on cAMP accumulation of GLP-1 or GLP-1(9&#x02013;36)
stimulated INS-1 cells in combination with DMSO, <strong>BETP</strong> or 2-sulfonyl
pyrimidines (<strong>A1</strong>, <strong>A2</strong>). <strong>BETP</strong> did not show a
significant positive effect on GLP-1 treatment but was able to convert
GLP-1(9&#x02013;36) signaling from initially inverse agonism to around 50 percent
receptor activation (106% increase of efficacy). 2-sulfonyl pyrimidines
<strong>A1</strong> and <strong>A2</strong> displayed comparable PAM activity on
partial agonist GLP-1(9&#x02013;36), showing 84% elevation of efficacy, while
demonstrating a 2-fold leftward shift of the dose-response curve together with a
20% increase of basal activity toward full agonist GLP-1. Similarly, compound
<strong>A3</strong>, a structural 2-sulfonyl pyrimidines analog with higher
GLP-1R selectivity, exerted strong PAM activity on GLP-1(9&#x02013;36) in INS-1
cells comparable to <strong>BETP</strong> leading to a 105% gain of efficacy and
demonstrated positive cooperativity toward GLP-1 like its close structural
analogs <strong>A1</strong> and <strong>A2</strong>. By contrast, both 2-mercapto
pyrimidine analogs, <strong>B1</strong> and <strong>B2</strong>, demonstrated rather
negative effects on basal receptor activation with only negligible effects on
peptide ligand potencies (<a href="/pmc/articles/PMC8146373/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6B</span></a>). 2-Amino
pyrimidine <strong>C4</strong> and <strong>C9</strong> analogs addition resulted in a
similar profile but very minor increase of basal activation (<a href="/pmc/articles/PMC8146373/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6C</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC8146373/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412322375488"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412322375488"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Select SCTR PAMs potentiate stimulatory and insulinotropic effects in
pancreatic rat insulinoma cell line:</strong><p id="P64">cAMP dose-response of (A, B, C, left to right) GLP-1 and
GLP-1(9&#x02013;36) in INS-1 cells treated with DMSO (black), 12.5&#x02013;25
&#x003bc;M of (A, B) <strong>BETP</strong> (purple) or 2-sulfonyl pyrimidines
<strong>A1</strong> (dark green), <strong>A2</strong> (light green), <strong>A3</strong>
(light blue-green), (C, D) 2-mercapto pyrimidines <strong>B1</strong> (light blue),
<strong>B2</strong> (dark blue) or (E, F) 2-amino pyrimidines <strong>C4</strong>
(light red), <strong>C9</strong> (dark red); TR-FRET ratios resulting from cAMP
accumulation normalized to GLP-1; graphs plotted using GraphPad Prism;
experiments performed in duplicate in at least three independent experiments;
data points shown as mean &#x000b1; SEM. Statistical significance determined
using GraphPad Prism&#x02019;s unpaired t-test corrected with Holm-Sidak method.
(D) Increase of insulin secretion compared to DMSO (black) in DMSO or
GLP-1(9&#x02013;36) co-treated INS-1 cells with 20 &#x003bc;M of <strong>BETP</strong>
(purple), <strong>A1</strong> (dark green), <strong>A2</strong> (light green),
<strong>A3</strong> (light blue-green), <strong>B1</strong> (light blue),
<strong>B2</strong> (dark blue), <strong>C9</strong> (red) or negative control
compound (NEG CTRL, beige); TR-FRET ratio resulting from insulin secretion
converted to insulin concentration (ng/mL) per source well and plotted as bar
graphs using GraphPad Prism 8.4.0.; experiments were performed as quintuplicates
in three independent experiments and data is presented as mean &#x000b1; SD;
statistical significance was determined using ordinary two-way ANOVA and
Tukey&#x02019;s multiple comparisons test (99% confidence interval). P values
were illustrated according to the following classification: (*<em>p</em>
= 0.01&#x02013;0.05), (**<em>p =</em> 0.01&#x02013;0.001),
(***<em>p</em> = 0.001&#x02013;0.0001), (****<em>p</em>
&#x0003c; 0.0001).</p></div></div></div><p id="P43" class="p p-last">To further explore biologically relevant activities, we utilized the
INS-1 cell line in a glucose-stimulated insulin secretion (GSIS) experiment
(<a href="/pmc/articles/PMC8146373/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6D</span></a>). Since a previous study
investigating <strong>BETP</strong> effects on insulin secretion in isolated mouse
islets revealed <strong>BETP</strong> was most effective together with
GLP-1(9&#x02013;36) in a high glucose environment [<a href="#R7" rid="R7" class=" bibr popnode">7</a>], we focused on evaluating test compounds (<strong>BETP</strong>,
<strong>A1</strong>, <strong>A2</strong>, <strong>A3</strong>, <strong>B1</strong>,
<strong>B2</strong> and <strong>C9</strong>) in these conditions, studying
synergistic compound effects in combination with high glucose concentrations (15
mM) and with or without GLP-1(9&#x02013;36) stimulation. As negative control, we
utilized a compound that was inactive in cAMP assays on GLP-1R-expressing cell
lines (data not shown). We determined statistical significance of compound or
ligand treatment as well as of interactions between compound and ligand
treatment in GraphPad Prism applying ordinary two-way ANOVA and Tukey&#x02019;s
multiple comparisons test with individual variances computed for each
comparison. In the absence of GLP-1(9&#x02013;36), insulin secretion was
significantly enhanced by <strong>BETP</strong>, <strong>C9</strong>
(****<em>p</em> &#x0003c; 0.0001), <strong>A1</strong>, <strong>A2</strong>,
<strong>B1</strong> (**<em>p</em> &#x0003c; 0.01) and <strong>B2</strong>
(*<em>p</em> &#x0003c; 0.05). Co-stimulation with GLP-1(9&#x02013;36)
elevated insulin secretion for all tested analogs, which was more significant
for <strong>BETP</strong>, <strong>A1</strong>, <strong>A2</strong> and <strong>C9</strong>
(****<em>p</em> &#x0003c; 0.0001) than <strong>B2</strong>
(***<em>p</em> &#x0003c; 0.001) or <strong>B1</strong>
(**<em>p</em> &#x0003c; 0.01). Surprisingly, 2-sulfonyl pyrimidine
<strong>A3</strong> did not enhance insulin secretion in either condition.
Further analysis accredited solely <strong>BETP</strong> (****<em>p</em>
&#x0003c; 0.0001) and <strong>A1</strong> (***<em>p</em> = 0.0005)
significant interactions with GLP-1(9&#x02013;36). The negative control did not
display any significant effects.</p></div><div id="S31" class="sec"><h3 id="S31title">3.8. Scaffold A demonstrates electrophilic reactivity and potential covalent
mechanism of action</h3><p id="P44" class="p p-first-last">As reported in previous studies [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R20" rid="R20" class=" bibr popnode">20</a>], <strong>Compound A</strong>
and <strong>BETP</strong> belong to a group of GLP-1R PAMs that act via covalent
modification of cysteine 347 (Cys-347, C347) in GLP1-Rs. Furthermore, 2-sulfonyl
pyrimidines constituting the core structure shared between <strong>Compound
A</strong> (<a href="/pmc/articles/PMC8146373/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a>, 1.) and group A
analogs, have been shown to alkylate cysteines via a nucleophilic aromatic
substitution reaction due to electron deficiency at position 2. To determine the
potential electrophilic reactivity of analogs incorporating scaffold A, we
incubated <strong>A1</strong> with glutathione (GSH) for up to four hours and
monitored putative <strong>A1-GS adduct</strong> formation via HPLC/MS. Indeed, we
observed a complete conversion of <strong>A1</strong> into <strong>A1-GS adduct</strong>
and <strong>A1-sulfinic acid</strong> (<a href="/pmc/articles/PMC8146373/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7A</span></a>)
already after 5 minutes reaction time. In parallel, we performed the same
experiment using 2-mercapto pyrimidine <strong>B2</strong>. In accordance with its
lower electrophilicity, we did not observe GS-adduct formation in up to 4 hours
of incubation with <strong>B2</strong> at 37 &#x000b0;C. Having confirmed that
2-sulfonyl pyrimidines are capable of covalently modifying cysteines, we
investigated PAM scaffolds in a cell-based setting with respect to a potential
irreversible MOA. Inspired by a previously reported compound-washout cAMP assay
[<a href="#R20" rid="R20" class=" bibr popnode">20</a>], we recorded cAMP accumulation
in SCTR-overexpressing CHO-K1 cells (<a href="/pmc/articles/PMC8146373/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig.
7B</span></a>) or GLP-1R-overexpressing HEK-293T cells (<a href="/pmc/articles/PMC8146373/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7C</span></a>, pretreated with test compounds prior to a
triple wash step. The corresponding peptide ligands Sec-FL and GLP-1 were added
after the washout of PAMs. Intriguingly, 2-sulfonyl pyrimidines <strong>A1</strong>
and <strong>A2</strong> maintained the ability to augment the cAMP response of
Sec-FL after washout supporting a potential covalent attachment to SCTRs as the
basis for PAM function. In contrast, 2-mercapto pyrimidine <strong>B2</strong> and
2-amino pyrimidine <strong>C9</strong> lost their positive cooperativity if added
prior to the washout confirming the reversible nature of these two scaffolds. We
observed similar responses with GLP-1Rs (<a href="/pmc/articles/PMC8146373/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig.
7C</span></a>). <strong>BETP</strong> and 2-sulfonyl pyrimidines <strong>A1</strong> and
<strong>A2</strong> exerted substantial intrinsic activity manifested as an
elevation of basal response for both conditions, added before or after the wash
step. In this case, a pretreatment of the electrophilic compounds seemed to
further enhance their effects on GLP-1Rs.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC8146373/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412322363392"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0007.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0007.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412322363392"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Scaffold A but not B and C demonstrate electrophilic reactivity and potential
covalent mechanism of action:</strong><p id="P65">(A) Covalent reaction of glutathione (GSH) and <strong>A1</strong> leading
to the formation CMPD A1- GS adduct and CMPD A1 sulfinic acid confirmed by
HPLC-MS analysis. cAMP dose-response curves of (B) Sec-FL stimulating SCTRs and
(C) GLP-1 stimulating GLP-1Rs; both pre-treated (dotted lines) prior a triple
wash step with DMSO, irreversible scaffold A (<strong>A1</strong> wash,
<strong>A2</strong> wash, <strong>BETP</strong> wash, left panels) or reversible
scaffolds (<strong>B2</strong> wash, <strong>C9</strong> wash, right panels) as well as
co-treated (solid lines) with DMSO, irreversible scaffold A (<strong>A1</strong>,
<strong>A2</strong>, <strong>BETP</strong>, left panels) or reversible scaffolds
(<strong>B2</strong>, <strong>C9</strong>, right panels) added after wash; TR-FRET
ratios resulting from cAMP accumulation normalized to corresponding agonist;
graphs plotted using GraphPad Prism; experiments performed in duplicate in at
least three independent experiments; data points shown as mean &#x000b1; SEM.
Statistical significance determined using GraphPad Prism&#x02019;s unpaired
t-test corrected with Holm-Sidak method, &#x003b1; = 0.01; (B) all potency shifts
statistically significant (p &#x0003c; 0.01) if not indicated otherwise (ns = not
significant); (C) EC<sub>50</sub> shifts for all conditions not statistically
significant except <strong>BETP</strong> wash (p &#x0003c; 0.01) and C9 (p &#x0003c;
0.05). Intrinsic activity (% basal activity) statistically significant (p
&#x0003c; 0.01) for <strong>BETP</strong>, <strong>BETP</strong> wash, <strong>A1</strong>,
<strong>A1</strong> wash, <strong>A2</strong> and <strong>A2</strong> wash.</p></div></div></div></div><div id="S32" class="sec sec-last"><h3 id="S32title">3.9. Mutational studies reveal a putative secondary mechanism for 2-sulfonyl
pyrimidines</h3><p id="P45" class="p p-first">Encouraged by these strong indications for covalent MOAs of 2-sulfonyl
pyrimidines, we explored their utility as tools to investigate their potential
site of interaction with both receptors. Since Cys-347<sup>6.36</sup> was
determined to be the site of action for <strong>BETP</strong> and related compounds
[<a href="#R20" rid="R20" class=" bibr popnode">20</a>], we performed a sequence
alignment (GPCRdb) of SCTR and GLP-1R. As expected, we found no cysteine, but a
lysine (Lys-317<sup>6.36</sup>) at the analogous position in SCTRs (<a href="/pmc/articles/PMC8146373/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Fig. 8A</span></a>). Depending on the structural
environment, lysine residues have been shown to be covalently modified by
electrophilic chemotypes [<a href="#R44" rid="R44" class=" bibr popnode">44</a>], however,
we considered it less likely, since there was no evidence for this conjugation
with 2-sulfonyl pyrimidines. Nevertheless, we continued with site-directed
mutagenesis yielding GLP-1R C347A (cysteine-to-alanine), SCTR K317A
(lysine-to-alanine) and SCTR K317C (lysine-to-cysteine) constructs to
investigate a possible common site of interaction on both receptors. Wild type
(WT) and mutant constructs were transiently expressed in HEK-293 cells and their
PAM responses on corresponding peptide ligands in cAMP accumulation assays were
compared. Intrinsic agonist and cooperative effects of <strong>BETP</strong> on
GLP-1(9&#x02013;36) were eradicated in the GLP-1R C347A mutant (<a href="/pmc/articles/PMC8146373/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Fig. 8B</span></a>), which validated the results of a previous
study [<a href="#R20" rid="R20" class=" bibr popnode">20</a>]. We detected a substantial
loss of activities for 2-sulfonyl pyrimidines <strong>A1</strong>, <strong>A2</strong>
and <strong>A3</strong> toward GLP-1(9&#x02013;36) stimulating GLP-1R C347A compared
to WT receptor, however, the PAM effect was not completely forfeited and the
potentiating activity for GLP-1 even remained in the same range. Of note,
structural analog <strong>A3</strong> lost its intrinsic activity at the GLP-1R
C347A mutant whereas the increased basal activation of <strong>A1</strong> and
<strong>A2</strong> was consistent in both, WT and mutant receptors. To ensure
that lack of PAM activities of putative irreversible scaffolds was caused by the
missing cysteine and not by potential receptor conformational arrangements
induced by the mutation, we additionally tested 2-mercapto pyrimidines
<strong>B1</strong> and <strong>B2</strong> as reversible control compounds on GLP-1
C347A (<a href="/pmc/articles/PMC8146373/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Fig. 8C</span></a>). As expected, cooperative
activities of both compounds remained unchanged in cells expressing the GLP-1R
C347A mutant receptor.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F8" co-legend-rid="lgnd_F8"><a href="/pmc/articles/PMC8146373/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327902624"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0008.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0008.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0008.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412327902624"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F8"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8">Figure 8:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Irreversible scaffold A acts likely via two distinct mechanisms:</strong><p id="P66">(A) Sequence alignment of SCTR and GLP-1R, specifically TM5, ICL3 and
TM6 and highlighting homolog residues C347<sup>GLP&#x02212;1R</sup> and
K317<sup>SCTR</sup>; generated by GPCRdb. cAMP dose-response of (B, C, top
panels) GLP-1, (B, C, bottom panels) GLP-1(9&#x02013;36), Sec-FL (D, E, top
panels) or Sec(3&#x02013;27) (D, E, bottom panels) stimulating (B, C, left
panels) GLP-1R-WT, (B, C, right panels) GLP-1R C347A, (D, E, left panels) SCTR
WT, (D, E, middle panels) SCTR K317A or (D, E, right panels) SCTR K317C treated
with DMSO (black), 12.5&#x02013;25 &#x003bc;M of (B, D) <strong>BETP</strong> (purple)
or 2-sulfonyl pyrimidines <strong>A1</strong> (dark green), <strong>A2</strong> (light
green), <strong>A3</strong> (light blue-green) or (C, E) 2-mercapto pyrimidines
<strong>B1</strong> (light blue), <strong>B2</strong> (dark blue); TR-FRET ratios
resulting from cAMP accumulation normalized to corresponding ligands; graphs
plotted using GraphPad Prism; experiments performed in duplicate in at least
three independent experiments; data points shown as mean &#x000b1; SEM.
Statistical significance for EC<sub>50</sub> shifts determined using GraphPad
Prism&#x02019;s unpaired t-test corrected with Holm-Sidak method, &#x003b1; =
0.01; all results statistically significant (p &#x0003c; 0.01) if not indicated
otherwise (ns = not significant).</p></div></div></div><p id="P46">Similarly, we generated and characterized SCTR K317A and SCTR K317C to
investigate whether the MOA of our compounds is covalent attachment to Lys-317
and to determine whether incorporation of a cysteine residue at the homologous
position at SCTRs would further increase sensitivity toward <strong>BETP</strong> as
it was reported for glucagon receptors (GCGRs) [<a href="#R20" rid="R20" class=" bibr popnode">20</a>], respectively. To ensure functional integrity of receptor
constructs, we subjected transiently expressing COS-1 cells to radioligand
binding experiments using
<sup><em>125</em></sup><em>I-Tyr</em><sup><em>10</em></sup>-secretin
and Sec-FL. Both, SCTR K317A and SCTR K317C, were able to maintain the ability
to bind secretin peptides similarly to WT SCTRs (<a href="/pmc/articles/PMC8146373/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T2"><h3>Table 2:</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Binding and biological activity parameters for SCTR mutant constructs
expressed in COS-1 cells</strong><p id="P69">Values are expressed in means &#x000b1; SEM from 4 independent
experiments performed in duplicate.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Constructs</th><th align="center" valign="middle" rowspan="1" colspan="1">pKi</th><th align="center" valign="middle" rowspan="1" colspan="1">pEC<sub>50</sub></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">SCTR WT</td><td align="center" valign="middle" rowspan="1" colspan="1">9.2&#x000b1;0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">11.6&#x000b1;0.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SCTR (K317C)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.7&#x000b1;0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">10.9&#x000b1;0.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SCTR (K317A)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.9&#x000b1;0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">10.5&#x000b1;0.2</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140412325328368"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/table/T2/?report=objectonly">Open in a separate window</a></div></div><p id="P47" class="p p-last">In addition, we transiently transfected the SCTR constructs in HEK-293
cells and tested effect of the mutations on responses of A and B group compounds
in cAMP assays (<a href="/pmc/articles/PMC8146373/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Fig. 8D</span></a> and <a href="/pmc/articles/PMC8146373/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">andE).</span></span><span>E</span></a>). Compared to WT receptors, secretin peptides
demonstrated a similar activation profile on both receptor mutants even though
potencies against SCTRs K317C were slightly reduced by two to three-fold.
Strikingly, neither mutating Lys-317 to alanine nor to cysteine had an impact on
the potentiating effects of irreversible analogs <strong>BETP</strong>,
<strong>A1</strong> or <strong>A2</strong>. Surprisingly, reversible control
<strong>B2</strong> seemed less effective on SCTR K317A receptors. Based on
these results, we concluded that covalent modulators target very likely an
allosteric binding site at SCTRs distinct from the reported site of interaction
at GLP-1Rs [<a href="#R21" rid="R21" class=" bibr popnode">21</a>].</p></div></div><div id="S33" class="tsec sec"><h2 class="head no_bottom_margin" id="S33title">4. Discussion</h2><p id="P48" class="p p-first">Here we report the discovery and detailed characterization of three
structurally related scaffolds that originated from a HTS screening campaign against
SCTRs. Expansion of structural analogs within scaffold sets and subsequent SAR
studies led to the selection of two promising derivatives from each group for
detailed allosteric activity studies and analysis of effects in naturally
SCTR-expressing NG108 cells. Intriguingly, we recognized that our newly discovered
SCTR PAMs share their core scaffold with reported GLP-1R activators <strong>Compound
A</strong> and <strong>BETP</strong>. Based on this structural similarity, we screened
novel SCTR PAMs against GLP-1Rs and determined probe-dependent activities for
scaffold groups in GLP-1R-overexpressing and endogenously expressing cell lines.
Moreover, we distinguished between irreversibly and reversibly acting analogs based
on their electrophilicity at the 2-position of the pyrimidine ring, further
confirmed by GSH-reactivity and wash-out experiments. Mutational studies at position
6.36 at both, GLP-1Rs and SCTRs, not only confirmed a common covalent MOA for
scaffold A with other GLP-1R PAMs such as <strong>BETP</strong>, but also discerned
reversible interactions with compounds <strong>B1</strong> and <strong>B2</strong> and
indicated a secondary mechanism for 2-sulfonyl pyrimidine analogs.</p><div id="S34" class="sec"><h3 id="S34title">4.1. Irreversible 2-sulfonyl pyrimidine scaffold likely acts via an alternative
mechanism in addition to Cys347<sup>GLP&#x02212;1R</sup> alkylation</h3><p id="P49" class="p p-first">We identified the 4-phenyl-6-trifluoromethyl pyrimidine core as a shared
structural motif amongst 2-sulfonyl pyrimidines (group A), 2-mercapto
pyrimidines (group B), 2-amino pyrimidines (groupC) and <strong>BETP</strong>, which
belongs to a group of characterized GLP-1R ago-PAMs [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R12" rid="R12" class=" bibr popnode">12</a>, <a href="#R19" rid="R19" class=" bibr popnode">19</a>, <a href="#R20" rid="R20" class=" bibr popnode">20</a>]. Beyond that, similarly to <strong>BETP</strong> 2-sulfonyl
pyrimidines incorporate an electrophilic moiety, which is crucial for the
potentiating effects of many GLP-1R allosteric modulators by covalently
modifying Cys-347 located at TM6 close to intracellular loop (ICL) 3, which
leads to stabilization of GLP-1R active conformation by promoting engagement
with G proteins via formation of a 90&#x000b0; kink in TM6. Willard, et. al.
[<a href="#R19" rid="R19" class=" bibr popnode">19</a>] developed a putative binding
model of <strong>BETP</strong> in G-protein bound GLP-1Rs (<a href="/pmc/articles/PMC8146373/figure/F9/" target="figure" class="fig-table-link figpopup" rid-figpopup="F9" rid-ob="ob-F9" co-legend-rid="lgnd_F9"><span>Fig. 9A</span></a>). Besides an irreversible linkage to Cys-347,
they proposed additional halogen-bonding interactions between the
trifluoromethyl group and the positively charged &#x003b5;-amino function of K346
as well as attractions of the aromatic moieties by hydrophobic amino acid
residues (F324, I328, V332, L354) through van-der-Waals forces. Mutagenesis
studies with C347 mutant receptors supported that the activity of 2-sulfonyl
pyrimidines on GLP-1Rs was predominantly dependent on a putative covalent
interaction with Cys-347. Thus, structural modifications targeting the linker or
the aniline ring (ring C) should play a minor role in GLP-1R modulation with the
4-phenyl-6-trifluoromethyl pyrimidine moiety residing in the proposed allosteric
binding pocket (<a href="/pmc/articles/PMC8146373/figure/F9/" target="figure" class="fig-table-link figpopup" rid-figpopup="F9" rid-ob="ob-F9" co-legend-rid="lgnd_F9"><span>Fig. 9B</span></a>, <a href="/pmc/articles/PMC8146373/figure/F9/" target="figure" class="fig-table-link figpopup" rid-figpopup="F9" rid-ob="ob-F9" co-legend-rid="lgnd_F9"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,C).</span></span><span>C</span></a>). Therefore, 2-sulfonyl pyrimidines can be
distinguished between A1-like compounds incorporating a 3, 4-methoxy
substitution, and A3-like analogs which bear a 2-methoxy group instead. Both
types of 2-sulfonyl pyrimidines are lacking the 3-benzyloxy function that is
part of the <strong>BETP</strong> molecule, resulting in a dramatic loss of potency
(<a href="/pmc/articles/PMC8146373/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>) in both cases, putatively
due to missing hydrophobic interactions with F324 and I328. Since
<strong>A3</strong> displayed significantly higher responses in GLP-1R related
cAMP assays and was more affected by the cysteine-to-alanine mutation than its
direct analog <strong>A1</strong>, we hypothesized that the hydroxy function of
threonine T353 might be involved in potential hydrogen-bonding interactions with
the 2- or 3-methoxy substituents in scaffold A analogs. In addition, A3-like
analog <strong>A12</strong> demonstrated similar superior activity in GLP-1R cAMP
assays, which supports the relevance of the 2-methoxy group and negligibility of
the butanamide linker and third aromatic moiety in order to interact with
GLP-1Rs. Interestingly, <strong>A11</strong> suffered from a loss of potency likely
due to the difluoromethyl substitution and/or the lack of the 2-methoxy function
supporting receptor-ligand interactions proposed in the binding model.
Otherwise, the number and location of methoxy substituents as well as the nature
of the tail attached to sulfonyl groups could influence the on-rate of
compounds, their positioning for Cys-347 engagement and the ability to pass
through the cell membrane, which is required to act via Cys-347 and the
surrounding binding pocket. This prerequisite could also explain the inactivity
of the butyric acid analog <strong>A10</strong>. In addition, our mutational studies
revealed that the potentiating effects of scaffold A analogs could not be
completely diminished by replacing the nucleophilic cysteine residue. Hence, we
assume the existence of a second allosteric mechanism, either through reversible
effects or interactions with a second binding site that is not targeted by
<strong>BETP</strong> and could further explain SAR of analogs.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F9" co-legend-rid="lgnd_F9"><a href="/pmc/articles/PMC8146373/figure/F9/" target="figure" rid-figpopup="F9" rid-ob="ob-F9"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140412327897984"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8146373_nihms-1674663-f0009.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1674663-f0009.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8146373/bin/nihms-1674663-f0009.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140412327897984"><a target="object" rel="noopener" href="/pmc/articles/PMC8146373/figure/F9/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F9"><div><a class="figpopup" href="/pmc/articles/PMC8146373/figure/F9/" target="figure" rid-figpopup="F9" rid-ob="ob-F9">Figure 9:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Comparison of BETP and 2-sulfonyl pyrimidines covalently bound to
active-state GLP-1Rs:</strong><p id="P67">Model of BETP&#x02019;s (purple sticks, left panel) binding pocket,
adapted from ref. [<a href="#R19" rid="R19" class=" bibr popnode">19</a>], illustrating
covalent modification of Cys347 in TM6 at the GLP-1R (cyan) in active
conformation and additional putative influences of surrounding residues, such as
van-der Waals interactions with hydrophobic residues or halogen attraction of
Lys346; model was modified for A1-like (green sticks, middle panel) and A3-like
(pale blue sticks, right panel) 2-sulfonyl pyrimidine analogs; illustrations
generated using Chimera 1.13.1.</p></div></div></div><p id="P50" class="p p-last">Beyond targeting GLP-1Rs, 2-sulfonyl pyrimidines show PAM activities
toward SCTRs superior to <strong>BETP</strong>, which are also likely due to a
covalent mechanism as supported by washout experiments. Our mutagenesis studies
suggested that newly discovered 2-sulfonyl pyrimidines do not discriminate
between WT, K317A or K317C SCTRs and therefore do not target an allosteric
binding site at SCTRs equivalent to the pocket in GLP-1Rs. In contrast to the
phenylalanine-to-cysteine substitution in GCGRs, the lysine-to-cysteine mutation
could not engender sensitivity to <strong>BETP</strong> in SCTRs. Even though
alignment of SCTR and GLP-1R sequence by GPCRdb suggested Lys-317<sup>SCTR</sup>
as the homolog residue, a multiple sequence alignment of class B GPCRs proposed
Cys-347<sup>GLP&#x02212;1R</sup> might be the result of a single amino acid
insertion that had occurred within a glucagon receptor sub-family (GLP-1R,
GLP-2R, GCGR and GIPR) [<a href="#R19" rid="R19" class=" bibr popnode">19</a>]. Thus, our
results might lack direct comparability to the GCGR study. Nevertheless, the
indifference toward SCTR K317A lacking the potential halogen interaction
partner, supports the hypothesis of an alternative site of interaction. Another
indicator that 2-sulfonyl pyrimidines may target a distinct location at SCTRs is
the different probe dependency profile in allosteric activity studies on SCTR or
GLP-1R-overexpressing cell lines comparing potentiating effects on full-length
or truncated peptides. While highly selective for the N-terminally truncated
analog GLP-1(9&#x02013;36) over full-length peptide GLP-1, analogs
<strong>A1</strong> and <strong>A2</strong> were less discriminating in case of
secretin and truncated analogs Sec(1&#x02013;23) and Sec(3&#x02013;27).
Furthermore, in an endogenous signaling environment scaffold A compounds
converted GLP-1(9&#x02013;36) from an inverse agonist to a partial agonist in
INS-1 cells whereas they were unable to rescue inactive Sec(3&#x02013;27) in the
NG108 cell line. Beyond that, we would expect that a PAM or allosteric agonist
targeting an allosteric hub at TM6 that is crucially involved in stabilizing the
active ligand-GPCR-G-protein ternary complex conformation, would lead to a
substantial increase in orthosteric agonist residence time as it has been shown
for <strong>BETP</strong> at GLP-1Rs [<a href="#R45" rid="R45" class=" bibr popnode">45</a>&#x02013;<a href="#R47" rid="R47" class=" bibr popnode">47</a>]. However, we
observed only minor increase of Fluo-Sec binding to SNAP-SCTRs overall and
negligible effects on Fluo-Sec dissociation for analogs incorporating the
2-sulfonyl pyrimidine scaffold A compared to reversible PAM scaffolds B and C.
Altogether, although our data strongly supports an alternative and possibly
shared allosteric mechanism for 2-sulfonyl pyrimidines on both, SCTRs and
GLP-1Rs, in addition to the thoroughly characterized modification of
Cys-347<sup>GLP&#x02212;1R</sup>, further investigations and mutational
studies are necessary to confirm and decipher the potential novel allosteric
binding site as well as its impact on SARs of structural analogs.</p></div><div id="S35" class="sec"><h3 id="S35title">4.2. Reversible analogs exert PAM activity with distinct selectivity
profiles</h3><p id="P51" class="p p-first">Since highly reactive compounds like 2-sulfonyl pyrimidines may be
impractical for drug development purposes, we were excited to have identified
two related scaffolds devoid of electrophilic reactivity. Glutathione
reactivity, cAMP washout and mutant receptor studies confirmed the absence of an
apparent covalent MOA for 2-mercapto pyrimidines, which validated that the
sulfur atom had not been targeted by air oxidation. Selectivity screens around
scaffold B revealed that a mono or di-methoxy substituted phenyl ring and/or a
methylated acetamide linker are crucial for significant PAM activity in both
SCTRs and GLP-1Rs. Since our SAR studies were solely based on commercially
available structural analogs, a synthetic approach would be necessary to
decipher the impact of individual functional groups, which was not part of the
current study. Focusing on the two most potent analogs <strong>B1</strong> and
<strong>B2</strong> differing from each other by one methoxy group at the core
phenyl ring, we determined surprisingly distinct selectivity profiles and probe
dependencies for the individual molecules. <strong>B1</strong> augmented not only
GLP-1(9&#x02013;36)&#x02013;triggered effects on GLP-1Rs to a much greater extent
than <strong>B2</strong> but also appeared to preferentially enhance Sec-FL and
Sec(1&#x02013;23) over Sec(3&#x02013;27) signaling. In contrast, beyond
significant cooperative activity toward potencies of full agonists Sec-FL and
Sec(1&#x02013;23), <strong>B2</strong> drastically potentiated both, potency and
efficacy, of SCTR signaling upon binding of partial agonist Sec(3&#x02013;27). In
NG108 cells expressing endogenous SCTR, this powerful enhancement was also
evident with <strong>B2</strong> being the only analog tested inducing a seven-fold
leftward shift of Sec(1&#x02013;23) dose-response and converting the inactive
Sec(3&#x02013;27) into a partial agonist. In addition, <strong>B2</strong> had by far
the greatest effect on prolonging residence time of Fluo-Sec at SNAP-SCTRs,
which was comparable to similar studies with <strong>BETP</strong> in SNAP-GLP-1Rs
[<a href="#R45" rid="R45" class=" bibr popnode">45</a>&#x02013;<a href="#R47" rid="R47" class=" bibr popnode">47</a>]. We hypothesized the formidable deceleration of
Fluo-Sec dissociation in conditions attenuating G protein coupling could be due
to either trapping the peptide ligand at the N-domain of the receptor or
stabilizing the receptor in an active-state conformation by binding to an
allosteric hub in the J-domain. Considering both the binding and functional data
of <strong>B2</strong>, we believe the latter explanation to be more likely. The
loss of activity in SCTR K317A might be another hint pointing to a potential
<strong>B2</strong> binding site but further studies, e.g. investigations on
ligand association kinetics or cooperative effects between individual PAM
scaffolds, are needed to support this hypothesis. Even though <strong>B1</strong>
and <strong>B2</strong> significantly enhanced GLP-1(9&#x02013;36)-stimulated GLP-1R
responses in overexpressing cell lines, both compounds decreased receptor basal
activity in naturally expressing INS-1 cells rather than having potentiating
effects on the partial agonist. Interestingly, while <strong>th-BETP</strong>, the
2-mercapto pyrimidine analog of <strong>BETP</strong>, was inactive in GLP-1R
overexpressing conditions [<a href="#R7" rid="R7" class=" bibr popnode">7</a>], another
study reported the discovery of a structural similar
3-(trifluoromethyl)quinoxaline, sharing the aniline substituted thioacetamide
with scaffold B analogs, by screening compounds against a constitutively active
GLP-1R C347QQYR mutant [<a href="#R48" rid="R48" class=" bibr popnode">48</a>]. As an aside,
unlike covalently acting 2-sulfonyl pyrimidines, reversible scaffolds B and C
displayed stronger potentiating effects at GLP-1Rs if added simultaneously with
the orthosteric agonist, supporting their preference to bind and act via
receptors in active confirmation (comparison of data not shown). Parental INS-1
cells displayed a very low sensitivity to GLP-1R stimulation with partial
agonist GLP-1(9&#x02013;36) even decreasing basal receptor activity implying an
overall low number of active receptor populations. Hence, we argued that the
augmenting activity of current 2-mercapto pyrimidines might be too weak to
intrinsically stabilize active receptor conformations and would need further
structural optimization to modulate responses in that setting. Interestingly, a
recent study [<a href="#R49" rid="R49" class=" bibr popnode">49</a>] identified a low
molecular weight, reversibly acting GLP-1R PAM via <em>in-silico</em>
screening against a predicted allosteric binding site in the TM domain based on
the recent cryo-EM structure of the GLP-1R-G protein complex (PDB ID: 5VAI)
[<a href="#R50" rid="R50" class=" bibr popnode">50</a>]. Subsequent site-specific
mutagenesis studies supported the presence of a novel allosteric binding pocket,
that is close to but distinct from the <strong>BETP</strong>-binding site, located
between TM6 and helix 8, at the interaction site of the alpha-helical C-term of
the G protein alpha subunit to GLP-1R [<a href="#R49" rid="R49" class=" bibr popnode">49</a>]. We concluded that in future studies it might be worthwhile to
investigate potential interactions of our novel reversible PAMs at this new
allosteric binding pocket, which might elucidate their preference for
co-stimulated receptors.</p><p id="P52" class="p p-last">For more detailed analysis of 2-amino pyrimidines, we concentrated on
two analogs <strong>C4</strong> and <strong>C9</strong> incorporating 3,4-dimethoxy
groups at the core phenyl ring, which appeared to be beneficial for modulation
of both, SCTRs and GLP-1Rs. Strikingly, both analogs elevated efficacies of
agonist peptides on SCTRs without pronounced discrimination between Sec-FL,
Sec(1&#x02013;23) and Sec(3&#x02013;27), while 2-amino pyrimidines strongly
favored the full-length peptide GLP-1 over partial agonist GLP-1(9&#x02013;36) on
GLP-1Rs, strongly suggesting different MOAs for modulating each receptor.
Unfortunately, <strong>C4</strong> and <strong>C9</strong> only showed marginal
potentiation of both Sec-FL and Sec(1&#x02013;23) signaling in NG108 and
insignificant activities in INS-1 cells, which reinforces that further
optimization might be necessary to achieve agents suitable to study the
receptors in an endogenous environment. As 2-amino pyrimidines were able to
double Sec-Fluo residence time at SNAP-SCTRs similarly to <strong>B1</strong>, we
assume both reversible scaffolds could target the same allosteric binding site
at SCTRs. In contrast, scaffold C exerted probe dependencies reverse to scaffold
B at GLP1-Rs implying different mechanisms. We hypothesize that while 2-mercapto
pyrimidines might act on or close to the established allosteric pocket of
<strong>BETP</strong>, 2-amino pyrimidines could target the alternative binding
site of 2-sulfonyl pyrimidines. However, further studies are needed to support
this hypothesis.</p></div><div id="S36" class="sec"><h3 id="S36title">4.3. Select analogs of irreversible and reversible scaffolds elevate insulin
secretion in INS-1 cells</h3><p id="P53" class="p p-first-last">GLP-1R activation by synthetic GLP-1 mimetics has become a crucial
treatment option for T2D improving pancreatic beta cell function and sensitivity
to glucose-stimulated insulin secretion (GSIS) [<a href="#R46" rid="R46" class=" bibr popnode">46</a>, <a href="#R51" rid="R51" class=" bibr popnode">51</a>]. To explore whether
newly discovered PAMs have a physiologically relevant effect on GLP-1R
signaling, we investigated the effect on GSIS of select analogs in INS-1 cells
with and without GLP-1(9&#x02013;36) co-stimulation and compared with
<strong>BETP</strong>. Strikingly, all but one analog significantly enhanced
secreted insulin concentrations in conditioned media. Similar to
GLP-1(9&#x02013;36)-mediated cAMP formation in INS-1 cells, <strong>BETP</strong>
demonstrated superior response in GSIS assays compared to our PAMs. At the same
time, substantial discrepancies became apparent when comparing compound
activities in modulating INS-1 cAMP accumulation and effects on insulin
secretion. For example, <strong>A3</strong>, demonstrating stronger potentiating
effects on GLP-1(9&#x02013;36) cAMP signaling in INS-1 cells than its structural
analogs <strong>A1</strong> and <strong>A2</strong>, was paradoxically inactive in GSIS,
while <strong>A1</strong> and <strong>A2</strong> had pronounced effects on
GLP-1(9&#x02013;36)-mediated insulin secretion. Similarly contradictory was the
substantial gain of insulin secretion upon <strong>C9</strong> treatment that lacked
significant activity in INS-1 cAMP assays. These results were unexpected since
several studies reported a tight correlation between rising cAMP levels and
promotion of insulin secretion in pancreatic beta cell lines [<a href="#R46" rid="R46" class=" bibr popnode">46</a>, <a href="#R52" rid="R52" class=" bibr popnode">52</a>]. It is
likely that the mechanism might be more complex and several signaling processes
influence GLP-1R-mediated GSIS, such as functional selectivity, receptor
internalization, nanodomain clustering, endosomal and compartmentalized cAMP
elevation and receptor-ligand binding kinetics [<a href="#R46" rid="R46" class=" bibr popnode">46</a>, <a href="#R47" rid="R47" class=" bibr popnode">47</a>, <a href="#R52" rid="R52" class=" bibr popnode">52</a>]. Unique signaling profiles of identified PAMs and
their analogs would help to elucidate underlying pharmacological signaling
pathways; however, investigations on these processes were outside the scope of
our study.</p></div><div id="S37" class="sec sec-last"><h3 id="S37title">4.4. Novel SCTR PAMs provide unique opportunities for developing tool compounds
and lead scaffolds</h3><p id="P54" class="p p-first-last">To our knowledge, we discovered and characterized the first small
molecule PAMs targeting SCTRs. By pursuing an ABC-driven approach, we were able
to optimize original hits leading to analog <strong>B2,</strong> which demonstrated
impressive cooperativity toward agonist-stimulated SCTR signaling. The disclosed
SCTR hit scaffolds have structural and functional similarity to some GLP-1R
agonists/PAMs. Both class B GPCRs are highly involved in mechanisms of metabolic
disorders. Even though newly discovered scaffolds were inferior to
<strong>BETP</strong> in GLP-1R stimulation, they suggest that the sulfone
moiety responsible for electrophilic reactivity and covalent modification of
Cys-347 at GLP-1Rs, could be replaced with a thioether or amino function without
eradicating PAM activity at GLP-1Rs. Both features have never been reported for
previous modulators of GLP-1Rs [<a href="#R7" rid="R7" class=" bibr popnode">7</a>, <a href="#R19" rid="R19" class=" bibr popnode">19</a>]. Moreover, for the first time we now
disclose the structures of small molecules able to interact and modulate SCTRs,
since only peptide ligands have been described so far [<a href="#R25" rid="R25" class=" bibr popnode">25</a>, <a href="#R29" rid="R29" class=" bibr popnode">29</a>, <a href="#R30" rid="R30" class=" bibr popnode">30</a>]. One example is the SCTR/GLP-1R
co-agonist GUB06&#x02013;046, a structural hybrid of Sec-FL and GLP-1, whose
administration has been shown to be beneficial for appetite regulation and
glucose homeostasis devoid of proliferative effects on exocrine or total
pancreas mass [<a href="#R11" rid="R11" class=" bibr popnode">11</a>]. The preservation of
beta cell mass by dual stimulation of SCTRs and GLP-1Rs indicates a potential
advantage compared with selective GLP-1 agonists. Hence, the discovery of orally
available small molecules targeting both of these receptors appears particularly
attractive. Our SAR studies of commercially available analogs provide useful
starting points for the development of highly efficient tool compounds through
further chemical optimization to decipher GLP-1R or SCTR-specific signaling
processes and drug development options for metabolic diseases, such as obesity
and diabetes. Beyond that, intensive allosteric activity analysis and mutational
studies led to the hypothesis of an alternative allosteric mechanism at both,
SCTRs and GLP-1Rs, building the foundation for future investigations to
elucidate a potential novel as well as distinct binding pocket applicable for
structure-based design of further low molecular weight and reversible agents on
these class B GPCRs.</p></div></div><div id="S38" class="tsec sec"><h2 class="head no_bottom_margin" id="S38title">Acknowledgements</h2><div class="sec"><p id="P55">This work was supported by a grant from the National Institutes of Health,
HL133501.</p></div></div><div id="fn-group-a.ax.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.ax.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"><p id="P56" class="p p-first">Declaration of Conflicting Interests</p><p id="P57" class="p p-last">We declare no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p></p><p class="fn sec" id="FN3"><p id="P58" class="p p-first-last"><strong>Publisher's Disclaimer: </strong>This is a PDF file of an unedited
manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will
undergo copyediting, typesetting, and review of the resulting proof before it is
published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.</p></p></div></div><div id="ref-list-a.ax.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.ax.ctitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">[1] <span class="mixed-citation">Wootten D, Miller LJ, <span class="ref-title">Structural Basis for Allosteric Modulation of Class B G
Protein-Coupled Receptors</span>, <span class="ref-journal">Annu Rev Pharmacol
Toxicol</span>
<span class="ref-vol">60</span> (2020)
89&#x02013;107. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7092389/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31454292" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol&#10;Toxicol&amp;title=Structural+Basis+for+Allosteric+Modulation+of+Class+B+G&#10;Protein-Coupled+Receptors&amp;author=D+Wootten&amp;author=LJ+Miller&amp;volume=60&amp;publication_year=2020&amp;pages=89-107&amp;pmid=31454292&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">[2] <span class="mixed-citation">Hoare SRJ, <span class="ref-title">Allosteric Modulators of Class B G-Protein-Coupled
Receptors</span>, <span class="ref-journal">Current Neuropharmacology</span>
<span class="ref-vol">5</span>(<span class="ref-iss">3</span>) (2007)
168&#x02013;179. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2656815/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19305799" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Neuropharmacology&amp;title=Allosteric+Modulators+of+Class+B+G-Protein-Coupled&#10;Receptors&amp;author=SRJ+Hoare&amp;volume=5&amp;issue=3&amp;publication_year=2007&amp;pages=168-179&amp;pmid=19305799&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">[3] <span class="mixed-citation">Afroze S, Meng F, Jensen K, McDaniel K, Rahal K, Onori P, Gaudio E, Alpini G, Glaser SS, <span class="ref-title">The physiological roles of secretin and its
receptor</span>, <span class="ref-journal">Annals of Translational Medicine</span>
<span class="ref-vol">1</span>(<span class="ref-iss">3</span>) (2013)
29. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4200670/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25332973" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+Translational+Medicine&amp;title=The+physiological+roles+of+secretin+and+its&#10;receptor&amp;author=S+Afroze&amp;author=F+Meng&amp;author=K+Jensen&amp;author=K+McDaniel&amp;author=K+Rahal&amp;volume=1&amp;issue=3&amp;publication_year=2013&amp;pages=29&amp;pmid=25332973&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">[4] <span class="mixed-citation">de Graaf C, Song G, Cao C, Zhao Q, Wang MW, Wu B, Stevens RC, <span class="ref-title">Extending the Structural View of Class B
GPCRs</span>, <span class="ref-journal">Trends Biochem Sci</span>
<span class="ref-vol">42</span>(<span class="ref-iss">12</span>) (2017)
946&#x02013;960. [<a href="https://pubmed.ncbi.nlm.nih.gov/29132948" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biochem+Sci&amp;title=Extending+the+Structural+View+of+Class+B&#10;GPCRs&amp;author=C+de+Graaf&amp;author=G+Song&amp;author=C+Cao&amp;author=Q+Zhao&amp;author=MW+Wang&amp;volume=42&amp;issue=12&amp;publication_year=2017&amp;pages=946-960&amp;pmid=29132948&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">[5] <span class="mixed-citation">Dengler DG, Sun Q, Harikumar KG, Beutel J, Holleran J, Pollari S, Ma C-T, Miller LJ, Sergienko E, <span class="ref-title">Identification and Characterization of Dual-Acting Small
Molecule Modulators targeting Secretin Receptors</span>,
<span class="ref-journal">The FASEB Journal</span>
<span class="ref-vol">34</span>(<span class="ref-iss">S1</span>) (2020)
1&#x02013;1. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+FASEB+Journal&amp;title=Identification+and+Characterization+of+Dual-Acting+Small&#10;Molecule+Modulators+targeting+Secretin+Receptors&amp;author=DG+Dengler&amp;author=Q+Sun&amp;author=KG+Harikumar&amp;author=J+Beutel&amp;author=J+Holleran&amp;volume=34&amp;issue=S1&amp;publication_year=2020&amp;pages=1-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">[6] <span class="mixed-citation">Lagerstrom MC, Schioth HB, <span class="ref-title">Structural diversity of G protein-coupled receptors and
significance for drug discovery</span>, <span class="ref-journal">Nat Rev Drug
Discov</span>
<span class="ref-vol">7</span>(<span class="ref-iss">4</span>) (2008)
339&#x02013;57. [<a href="https://pubmed.ncbi.nlm.nih.gov/18382464" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug&#10;Discov&amp;title=Structural+diversity+of+G+protein-coupled+receptors+and&#10;significance+for+drug+discovery&amp;author=MC+Lagerstrom&amp;author=HB+Schioth&amp;volume=7&amp;issue=4&amp;publication_year=2008&amp;pages=339-57&amp;pmid=18382464&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">[7] <span class="mixed-citation">Bueno AB, Showalter AD, Wainscott DB, Stutsman C, Marin A, Ficorilli J, Cabrera O, Willard FS, Sloop KW, <span class="ref-title">Positive Allosteric Modulation of the Glucagon-like
Peptide-1 Receptor by Diverse Electrophiles</span>, <span class="ref-journal">J Biol
Chem</span>
<span class="ref-vol">291</span>(<span class="ref-iss">20</span>) (2016)
10700&#x02013;15. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4865917/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26975372" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol&#10;Chem&amp;title=Positive+Allosteric+Modulation+of+the+Glucagon-like&#10;Peptide-1+Receptor+by+Diverse+Electrophiles&amp;author=AB+Bueno&amp;author=AD+Showalter&amp;author=DB+Wainscott&amp;author=C+Stutsman&amp;author=A+Marin&amp;volume=291&amp;issue=20&amp;publication_year=2016&amp;pages=10700-15&amp;pmid=26975372&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">[8] <span class="mixed-citation">Sloop KW, Briere DA, Emmerson PJ, Willard FS, <span class="ref-title">Beyond Glucagon-like Peptide-1: Is G-Protein Coupled
Receptor Polypharmacology the Path Forward to Treating Metabolic
Diseases?</span>, <span class="ref-journal">ACS Pharmacology &#x00026; Translational
Science</span>
<span class="ref-vol">1</span>(<span class="ref-iss">1</span>) (2018)
3&#x02013;11. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7088942/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32219200" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Pharmacology+&#x00026;+Translational&#10;Science&amp;title=Beyond+Glucagon-like+Peptide-1:+Is+G-Protein+Coupled&#10;Receptor+Polypharmacology+the+Path+Forward+to+Treating+Metabolic&#10;Diseases?&amp;author=KW+Sloop&amp;author=DA+Briere&amp;author=PJ+Emmerson&amp;author=FS+Willard&amp;volume=1&amp;issue=1&amp;publication_year=2018&amp;pages=3-11&amp;pmid=32219200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">[9] <span class="mixed-citation">Brandler J, Miller LJ, Wang XJ, Burton D, Busciglio I, Arndt K, Harmsen WS, Camilleri M, <span class="ref-title">Secretin effects on gastric functions, hormones and
symptoms in functional dyspepsia and health: randomized crossover
trial</span>, <span class="ref-journal">Am J Physiol Gastrointest Liver
Physiol</span>
<span class="ref-vol">318</span>(<span class="ref-iss">4</span>) (2020)
G635&#x02013;G645. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7191464/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32036693" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Gastrointest+Liver&#10;Physiol&amp;title=Secretin+effects+on+gastric+functions,+hormones+and&#10;symptoms+in+functional+dyspepsia+and+health:+randomized+crossover&#10;trial&amp;author=J+Brandler&amp;author=LJ+Miller&amp;author=XJ+Wang&amp;author=D+Burton&amp;author=I+Busciglio&amp;volume=318&amp;issue=4&amp;publication_year=2020&amp;pages=G635-G645&amp;pmid=32036693&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">[10] <span class="mixed-citation">Congreve M, Oswald C, Marshall FH, <span class="ref-title">Applying Structure-Based Drug Design Approaches to
Allosteric Modulators of GPCRs</span>, <span class="ref-journal">Trends Pharmacol
Sci</span>
<span class="ref-vol">38</span>(<span class="ref-iss">9</span>) (2017)
837&#x02013;847. [<a href="https://pubmed.ncbi.nlm.nih.gov/28648526" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol&#10;Sci&amp;title=Applying+Structure-Based+Drug+Design+Approaches+to&#10;Allosteric+Modulators+of+GPCRs&amp;author=M+Congreve&amp;author=C+Oswald&amp;author=FH+Marshall&amp;volume=38&amp;issue=9&amp;publication_year=2017&amp;pages=837-847&amp;pmid=28648526&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">[11] <span class="mixed-citation">van Witteloostuijn SB, Dalboge LS, Hansen G, Midtgaard SR, Jensen GV, Jensen KJ, Vrang N, Jelsing J, Pedersen SL, <span class="ref-title">GUB06&#x02013;046, a novel secretin/glucagon-like peptide
1 co-agonist, decreases food intake, improves glycemic control, and
preserves beta cell mass in diabetic mice</span>, <span class="ref-journal">J Pept
Sci</span>
<span class="ref-vol">23</span>(<span class="ref-iss">12</span>) (2017)
845&#x02013;854. [<a href="https://pubmed.ncbi.nlm.nih.gov/29057588" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pept&#10;Sci&amp;title=GUB06&#x02013;046,+a+novel+secretin/glucagon-like+peptide&#10;1+co-agonist,+decreases+food+intake,+improves+glycemic+control,+and&#10;preserves+beta+cell+mass+in+diabetic+mice&amp;author=SB+van+Witteloostuijn&amp;author=LS+Dalboge&amp;author=G+Hansen&amp;author=SR+Midtgaard&amp;author=GV+Jensen&amp;volume=23&amp;issue=12&amp;publication_year=2017&amp;pages=845-854&amp;pmid=29057588&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">[12] <span class="mixed-citation">Sloop KW, Willard FS, Brenner MB, Ficorilli J, Valasek K, Showalter AD, Farb TB, Cao JX, Cox AL, Michael MD, Gutierrez Sanfeliciano SM, Tebbe MJ, Coghlan MJ, <span class="ref-title">Novel small molecule glucagon-like peptide-1 receptor
agonist stimulates insulin secretion in rodents and from human
islets</span>, <span class="ref-journal">Diabetes</span>
<span class="ref-vol">59</span>(<span class="ref-iss">12</span>) (2010)
3099&#x02013;107. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2992771/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20823098" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Novel+small+molecule+glucagon-like+peptide-1+receptor&#10;agonist+stimulates+insulin+secretion+in+rodents+and+from+human&#10;islets&amp;author=KW+Sloop&amp;author=FS+Willard&amp;author=MB+Brenner&amp;author=J+Ficorilli&amp;author=K+Valasek&amp;volume=59&amp;issue=12&amp;publication_year=2010&amp;pages=3099-107&amp;pmid=20823098&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">[13] <span class="mixed-citation">Morris LC, Nance KD, Gentry PR, Days EL, Weaver CD, Niswender CM, Thompson AD, Jones CK, Locuson CW, Morrison RD, Daniels JS, Niswender KD, Lindsley CW, <span class="ref-title">Discovery of
(S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-py
rrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant
glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator
(PAM)</span>, <span class="ref-journal">J Med Chem</span>
<span class="ref-vol">57</span>(<span class="ref-iss">23</span>) (2014)
10192&#x02013;7. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4266362/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25423411" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Discovery+of&#10;(S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-py&#10;rrido[3,4-b]indole-4-carboxamide+(VU0453379):+a+novel,+CNS+penetrant&#10;glucagon-like+peptide+1+receptor+(GLP-1R)+positive+allosteric+modulator&#10;(PAM)&amp;author=LC+Morris&amp;author=KD+Nance&amp;author=PR+Gentry&amp;author=EL+Days&amp;author=CD+Weaver&amp;volume=57&amp;issue=23&amp;publication_year=2014&amp;pages=10192-7&amp;pmid=25423411&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">[14] <span class="mixed-citation">Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, Christopoulos A, Sexton PM, <span class="ref-title">Modulation of the glucagon-like peptide-1 receptor
signaling by naturally occurring and synthetic flavonoids</span>,
<span class="ref-journal">J Pharmacol Exp Ther</span>
<span class="ref-vol">336</span>(<span class="ref-iss">2</span>) (2011)
540&#x02013;50. [<a href="https://pubmed.ncbi.nlm.nih.gov/21075839" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Modulation+of+the+glucagon-like+peptide-1+receptor&#10;signaling+by+naturally+occurring+and+synthetic+flavonoids&amp;author=D+Wootten&amp;author=J+Simms&amp;author=C+Koole&amp;author=OL+Woodman&amp;author=RJ+Summers&amp;volume=336&amp;issue=2&amp;publication_year=2011&amp;pages=540-50&amp;pmid=21075839&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">[15] <span class="mixed-citation">Cheong YH, Kim MK, Son MH, Kaang BK, <span class="ref-title">Two small molecule agonists of glucagon-like peptide-1
receptor modulate the receptor activation response
differently</span>, <span class="ref-journal">Biochemical and biophysical research
communications</span>
<span class="ref-vol">417</span>(<span class="ref-iss">1</span>) (2012)
558&#x02013;63. [<a href="https://pubmed.ncbi.nlm.nih.gov/22177947" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+and+biophysical+research&#10;communications&amp;title=Two+small+molecule+agonists+of+glucagon-like+peptide-1&#10;receptor+modulate+the+receptor+activation+response&#10;differently&amp;author=YH+Cheong&amp;author=MK+Kim&amp;author=MH+Son&amp;author=BK+Kaang&amp;volume=417&amp;issue=1&amp;publication_year=2012&amp;pages=558-63&amp;pmid=22177947&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">[16] <span class="mixed-citation">Morris LC, Days EL, Turney M, Mi D, Lindsley CW, Weaver CD, Niswender KD, <span class="ref-title">A Duplexed High-Throughput Screen to Identify Allosteric
Modulators of the Glucagon-Like Peptide 1 and Glucagon
Receptors</span>, <span class="ref-journal">J Biomol Screen</span>
<span class="ref-vol">19</span>(<span class="ref-iss">6</span>) (2014)
847&#x02013;58. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4306651/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24525870" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomol+Screen&amp;title=A+Duplexed+High-Throughput+Screen+to+Identify+Allosteric&#10;Modulators+of+the+Glucagon-Like+Peptide+1+and+Glucagon&#10;Receptors&amp;author=LC+Morris&amp;author=EL+Days&amp;author=M+Turney&amp;author=D+Mi&amp;author=CW+Lindsley&amp;volume=19&amp;issue=6&amp;publication_year=2014&amp;pages=847-58&amp;pmid=24525870&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">[17] <span class="mixed-citation">Knudsen LB, Kiel D, Teng M, Behrens C, Bhumralkar D, Kodra JT, Holst JJ, Jeppesen CB, Johnson MD, de Jong JC, Jorgensen AS, Kercher T, Kostrowicki J, Madsen P, Olesen PH, Petersen JS, Poulsen F, Sidelmann UG, Sturis J, Truesdale L, May J, Lau J, <span class="ref-title">Small-molecule agonists for the glucagon-like peptide 1
receptor</span>, <span class="ref-journal">Proceedings of the National Academy of
Sciences</span>
<span class="ref-vol">104</span>(<span class="ref-iss">3</span>) (2007)
937&#x02013;942. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1783418/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17213325" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of&#10;Sciences&amp;title=Small-molecule+agonists+for+the+glucagon-like+peptide+1&#10;receptor&amp;author=LB+Knudsen&amp;author=D+Kiel&amp;author=M+Teng&amp;author=C+Behrens&amp;author=D+Bhumralkar&amp;volume=104&amp;issue=3&amp;publication_year=2007&amp;pages=937-942&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">[18] <span class="mixed-citation">Eng H, Sharma R, McDonald TS, Edmonds DJ, Fortin JP, Li X, Stevens BD, Griffith DA, Limberakis C, Nolte WM, Price DA, Jackson M, Kalgutkar AS, <span class="ref-title">Demonstration of the innate electrophilicity of
4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine
(BETP), a small-molecule positive allosteric modulator of the glucagon-like
peptide-1 receptor</span>, <span class="ref-journal">Drug Metab Dispos</span>
<span class="ref-vol">41</span>(<span class="ref-iss">8</span>) (2013)
1470&#x02013;9. [<a href="https://pubmed.ncbi.nlm.nih.gov/23653442" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos&amp;title=Demonstration+of+the+innate+electrophilicity+of&#10;4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine&#10;(BETP),+a+small-molecule+positive+allosteric+modulator+of+the+glucagon-like&#10;peptide-1+receptor&amp;author=H+Eng&amp;author=R+Sharma&amp;author=TS+McDonald&amp;author=DJ+Edmonds&amp;author=JP+Fortin&amp;volume=41&amp;issue=8&amp;publication_year=2013&amp;pages=1470-9&amp;pmid=23653442&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">[19] <span class="mixed-citation">Willard FS, Ho JD, Sloop KW, <span class="ref-title">Discovery and pharmacology of the covalent GLP-1
receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R
pharmacology</span>, <span class="ref-journal">Adv Pharmacol</span>
<span class="ref-vol">88</span> (2020)
173&#x02013;191. [<a href="https://pubmed.ncbi.nlm.nih.gov/32416867" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Pharmacol&amp;title=Discovery+and+pharmacology+of+the+covalent+GLP-1&#10;receptor+(GLP-1R)+allosteric+modulator+BETP:+A+novel+tool+to+probe+GLP-1R&#10;pharmacology&amp;author=FS+Willard&amp;author=JD+Ho&amp;author=KW+Sloop&amp;volume=88&amp;publication_year=2020&amp;pages=173-191&amp;pmid=32416867&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">[20] <span class="mixed-citation">Nolte WM, Fortin JP, Stevens BD, Aspnes GE, Griffith DA, Hoth LR, Ruggeri RB, Mathiowetz AM, Limberakis C, Hepworth D, Carpino PA, <span class="ref-title">A potentiator of orthosteric ligand activity at GLP-1R
acts via covalent modification</span>, <span class="ref-journal">Nat Chem
Biol</span>
<span class="ref-vol">10</span>(<span class="ref-iss">8</span>) (2014)
629&#x02013;31. [<a href="https://pubmed.ncbi.nlm.nih.gov/24997604" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Chem&#10;Biol&amp;title=A+potentiator+of+orthosteric+ligand+activity+at+GLP-1R&#10;acts+via+covalent+modification&amp;author=WM+Nolte&amp;author=JP+Fortin&amp;author=BD+Stevens&amp;author=GE+Aspnes&amp;author=DA+Griffith&amp;volume=10&amp;issue=8&amp;publication_year=2014&amp;pages=629-31&amp;pmid=24997604&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">[21] <span class="mixed-citation">Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, Liu K, Cai X, Dai A, Lin G, Liu D, Wu F, Wu Y, Zhao S, Ye L, Han GW, Lau J, Wu B, Hanson MA, Liu ZJ, Wang MW, Stevens RC, <span class="ref-title">Human GLP-1 receptor transmembrane domain structure in
complex with allosteric modulators</span>, <span class="ref-journal">Nature</span>
<span class="ref-vol">546</span>(<span class="ref-iss">7657</span>) (2017)
312&#x02013;315. [<a href="https://pubmed.ncbi.nlm.nih.gov/28514449" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Human+GLP-1+receptor+transmembrane+domain+structure+in&#10;complex+with+allosteric+modulators&amp;author=G+Song&amp;author=D+Yang&amp;author=Y+Wang&amp;author=C+de+Graaf&amp;author=Q+Zhou&amp;volume=546&amp;issue=7657&amp;publication_year=2017&amp;pages=312-315&amp;pmid=28514449&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">[22] <span class="mixed-citation">Willard FS, Bueno AB, Sloop KW, <span class="ref-title">Small molecule drug discovery at the glucagon-like
peptide-1 receptor</span>, <span class="ref-journal">Exp Diabetes Res</span>
<span class="ref-vol">2012</span> (2012)
709893. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3352573/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22611375" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Diabetes+Res&amp;title=Small+molecule+drug+discovery+at+the+glucagon-like&#10;peptide-1+receptor&amp;author=FS+Willard&amp;author=AB+Bueno&amp;author=KW+Sloop&amp;volume=2012&amp;publication_year=2012&amp;pages=709893&amp;pmid=22611375&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">[23] <span class="mixed-citation">Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I, <span class="ref-title">Weight and Type 2 Diabetes after Bariatric Surgery:
Systematic Review and Meta-analysis</span>, <span class="ref-journal">The American
Journal of Medicine</span>
<span class="ref-vol">122</span>(<span class="ref-iss">3</span>) (2009)
248&#x02013;256.e5. [<a href="https://pubmed.ncbi.nlm.nih.gov/19272486" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+American&#10;Journal+of+Medicine&amp;title=Weight+and+Type+2+Diabetes+after+Bariatric+Surgery:&#10;Systematic+Review+and+Meta-analysis&amp;author=H+Buchwald&amp;author=R+Estok&amp;author=K+Fahrbach&amp;author=D+Banel&amp;author=MD+Jensen&amp;volume=122&amp;issue=3&amp;publication_year=2009&amp;pages=248-256.e5&amp;pmid=19272486&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">[24] <span class="mixed-citation">Modvig IM, Andersen DB, Grunddal KV, Kuhre RE, Martinussen C, Christiansen CB, Orskov C, Larraufie P, Kay RG, Reimann F, Gribble FM, Hartmann B, Bojsen-Moller KN, Madsbad S, Wewer Albrechtsen NJ, Holst JJ, <span class="ref-title">Secretin release after Roux-en-Y gastric bypass reveals
a population of glucose-sensitive S cells in distal small
intestine</span>, <span class="ref-journal">Int J Obes (Lond)</span>
(2020). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7445113/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32015474" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Obes+(Lond)&amp;title=Secretin+release+after+Roux-en-Y+gastric+bypass+reveals&#10;a+population+of+glucose-sensitive+S+cells+in+distal+small&#10;intestine&amp;author=IM+Modvig&amp;author=DB+Andersen&amp;author=KV+Grunddal&amp;author=RE+Kuhre&amp;author=C+Martinussen&amp;publication_year=2020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">[25] <span class="mixed-citation">Dong M, Harikumar KG, Raval SR, Milburn JE, Clark C, Alcala-Torano R, Mobarec JC, Reynolds CA, Ghirlanda G, Christopoulos A, Wootten D, Sexton PM, Miller LJ, <span class="ref-title">Rational development of a high-affinity secretin
receptor antagonist</span>, <span class="ref-journal">Biochem Pharmacol</span>
<span class="ref-vol">177</span> (2020) 113929. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7299832/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32217097" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;title=Rational+development+of+a+high-affinity+secretin&#10;receptor+antagonist&amp;author=M+Dong&amp;author=KG+Harikumar&amp;author=SR+Raval&amp;author=JE+Milburn&amp;author=C+Clark&amp;volume=177&amp;publication_year=2020&amp;pages=113929&amp;pmid=32217097&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">[26] <span class="mixed-citation">Grossini E, Molinari C, Morsanuto V, Mary DA, Vacca G, <span class="ref-title">Intracoronary secretin increases cardiac perfusion and
function in anaesthetized pigs through pathways involving beta-adrenoceptors
and nitric oxide</span>, <span class="ref-journal">Exp Physiol</span>
<span class="ref-vol">98</span>(<span class="ref-iss">5</span>) (2013)
973&#x02013;87. [<a href="https://pubmed.ncbi.nlm.nih.gov/23243148" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Physiol&amp;title=Intracoronary+secretin+increases+cardiac+perfusion+and&#10;function+in+anaesthetized+pigs+through+pathways+involving+beta-adrenoceptors&#10;and+nitric+oxide&amp;author=E+Grossini&amp;author=C+Molinari&amp;author=V+Morsanuto&amp;author=DA+Mary&amp;author=G+Vacca&amp;volume=98&amp;issue=5&amp;publication_year=2013&amp;pages=973-87&amp;pmid=23243148&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">[27] <span class="mixed-citation">Li Y, Schnabl K, Gabler S-M, Willersh&#x000e4;user M, Reber J, Karlas A, Laurila S, Lahesmaa M, u Din M, Bast-Habersbrunner A, Virtanen KA, Fromme T, Bolze F, O&#x02019;Farrell LS, Alsina-Fernandez J, Coskun T, Ntziachristos V, Nuutila P, Klingenspor M, <span class="ref-title">Secretin-Activated Brown Fat Mediates Prandial
Thermogenesis to Induce Satiation</span>, <span class="ref-journal">Cell</span>
<span class="ref-vol">175</span>(<span class="ref-iss">6</span>) (2018)
1561&#x02013;1574.e12. [<a href="https://pubmed.ncbi.nlm.nih.gov/30449620" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Secretin-Activated+Brown+Fat+Mediates+Prandial&#10;Thermogenesis+to+Induce+Satiation&amp;author=Y+Li&amp;author=K+Schnabl&amp;author=S-M+Gabler&amp;author=M+Willersh&#x000e4;user&amp;author=J+Reber&amp;volume=175&amp;issue=6&amp;publication_year=2018&amp;pages=1561-1574.e12&amp;pmid=30449620&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">[28] <span class="mixed-citation">Wu N, Meng F, Invernizzi P, Bernuzzi F, Venter J, Standeford H, Onori P, Marzioni M, Alvaro D, Franchitto A, Gaudio E, Glaser S, Alpini G, <span class="ref-title">The secretin/secretin receptor axis modulates liver
fibrosis through changes in transforming growth factor-beta1 biliary
secretion in mice</span>, <span class="ref-journal">Hepatology</span>
<span class="ref-vol">64</span>(<span class="ref-iss">3</span>) (2016)
865&#x02013;79. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4992423/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27115285" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=The+secretin/secretin+receptor+axis+modulates+liver&#10;fibrosis+through+changes+in+transforming+growth+factor-beta1+biliary&#10;secretion+in+mice&amp;author=N+Wu&amp;author=F+Meng&amp;author=P+Invernizzi&amp;author=F+Bernuzzi&amp;author=J+Venter&amp;volume=64&amp;issue=3&amp;publication_year=2016&amp;pages=865-79&amp;pmid=27115285&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">[29] <span class="mixed-citation">Singh K, Senthil V, Arokiaraj AW, Leprince J, Lefranc B, Vaudry D, Allam AA, Ajarem J, Chow BK, <span class="ref-title">Structure-Activity Relationship Studies of N- and
C-Terminally Modified Secretin Analogs for the Human Secretin
Receptor</span>, <span class="ref-journal">PLoS One</span>
<span class="ref-vol">11</span>(<span class="ref-iss">3</span>) (2016)
e0149359. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4773067/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26930505" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Structure-Activity+Relationship+Studies+of+N-+and&#10;C-Terminally+Modified+Secretin+Analogs+for+the+Human+Secretin&#10;Receptor&amp;author=K+Singh&amp;author=V+Senthil&amp;author=AW+Arokiaraj&amp;author=J+Leprince&amp;author=B+Lefranc&amp;volume=11&amp;issue=3&amp;publication_year=2016&amp;pages=e0149359&amp;pmid=26930505&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">[30] <span class="mixed-citation">Dengler DG, Sun Q, Holleran J, Pollari S, Beutel J, Brown BT, Shinoki Iwaya A, Ardecky R, Harikumar KG, Miller LJ, Sergienko EA, <span class="ref-title">Development of a Testing Funnel for Identification of
Small-Molecule Modulators Targeting Secretin Receptors</span>,
<span class="ref-journal">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span>
<span class="ref-vol">26</span>(<span class="ref-iss">1</span>) (2021)
1&#x02013;16. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8278649/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32749201" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=SLAS+DISCOVERY:+Advancing+the+Science+of+Drug+Discovery&amp;title=Development+of+a+Testing+Funnel+for+Identification+of&#10;Small-Molecule+Modulators+Targeting+Secretin+Receptors&amp;author=DG+Dengler&amp;author=Q+Sun&amp;author=J+Holleran&amp;author=S+Pollari&amp;author=J+Beutel&amp;volume=26&amp;issue=1&amp;publication_year=2021&amp;pages=1-16&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">[31] <span class="mixed-citation">Leach K, Sexton PM, Christopoulos A, <span class="ref-title">Allosteric GPCR modulators: taking advantage of
permissive receptor pharmacology</span>, <span class="ref-journal">Trends Pharmacol
Sci</span>
<span class="ref-vol">28</span>(<span class="ref-iss">8</span>) (2007)
382&#x02013;9. [<a href="https://pubmed.ncbi.nlm.nih.gov/17629965" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol&#10;Sci&amp;title=Allosteric+GPCR+modulators:+taking+advantage+of&#10;permissive+receptor+pharmacology&amp;author=K+Leach&amp;author=PM+Sexton&amp;author=A+Christopoulos&amp;volume=28&amp;issue=8&amp;publication_year=2007&amp;pages=382-9&amp;pmid=17629965&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">[32] <span class="mixed-citation">Ehlert FJ, <span class="ref-title">Estimation of the affinities of allosteric ligands using
radioligand binding and pharmacological null methods</span>,
<span class="ref-journal">Molecular pharmacology</span>
<span class="ref-vol">33</span>(<span class="ref-iss">2</span>) (1988)
187&#x02013;194. [<a href="https://pubmed.ncbi.nlm.nih.gov/2828914" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+pharmacology&amp;title=Estimation+of+the+affinities+of+allosteric+ligands+using&#10;radioligand+binding+and+pharmacological+null+methods&amp;author=FJ+Ehlert&amp;volume=33&amp;issue=2&amp;publication_year=1988&amp;pages=187-194&amp;pmid=2828914&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">[33] <span class="mixed-citation">Black JW, Leff P, <span class="ref-title">Operational models of pharmacological
agonism</span>, <span class="ref-journal">Proceedings of the Royal Society of London.
Series B. Biological Sciences</span>
<span class="ref-vol">220</span>(<span class="ref-iss">1219</span>) (1983)
141&#x02013;162. [<a href="https://pubmed.ncbi.nlm.nih.gov/6141562" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+Royal+Society+of+London.&#10;Series+B.+Biological+Sciences&amp;title=Operational+models+of+pharmacological&#10;agonism&amp;author=JW+Black&amp;author=P+Leff&amp;volume=220&amp;issue=1219&amp;publication_year=1983&amp;pages=141-162&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">[34] <span class="mixed-citation">Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P, <span class="ref-title">Glucose Sensitivity and Metabolism-Secretion Coupling
Studied during Two-Year Continuous Culture in INS-1E Insulinoma
Cells</span>, <span class="ref-journal">Endocrinology</span>
<span class="ref-vol">145</span>(<span class="ref-iss">2</span>) (2004)
667&#x02013;678. [<a href="https://pubmed.ncbi.nlm.nih.gov/14592952" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Glucose+Sensitivity+and+Metabolism-Secretion+Coupling&#10;Studied+during+Two-Year+Continuous+Culture+in+INS-1E+Insulinoma&#10;Cells&amp;author=A+Merglen&amp;author=S+Theander&amp;author=B+Rubi&amp;author=G+Chaffard&amp;author=CB+Wollheim&amp;volume=145&amp;issue=2&amp;publication_year=2004&amp;pages=667-678&amp;pmid=14592952&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">[35] <span class="mixed-citation">Lopata MA, Cleveland DW, Sollner-Webb B, <span class="ref-title">High level transient expression of a chloramphenicol
acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled
with a dimethyl sulfoxide or glycerol shock treatment</span>,
<span class="ref-journal">Nucleic Acids Res</span>
<span class="ref-vol">12</span>(<span class="ref-iss">14</span>) (1984)
5707&#x02013;17. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC320025/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6589587" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=High+level+transient+expression+of+a+chloramphenicol&#10;acetyl+transferase+gene+by+DEAE-dextran+mediated+DNA+transfection+coupled&#10;with+a+dimethyl+sulfoxide+or+glycerol+shock+treatment&amp;author=MA+Lopata&amp;author=DW+Cleveland&amp;author=B+Sollner-Webb&amp;volume=12&amp;issue=14&amp;publication_year=1984&amp;pages=5707-17&amp;pmid=6589587&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">[36] <span class="mixed-citation">Klein MT, Vinson PN, Niswender CM, <span class="ref-title">Approaches for probing allosteric interactions at 7
transmembrane spanning receptors</span>, <span class="ref-journal">Prog Mol Biol
Transl Sci</span>
<span class="ref-vol">115</span> (2013)
1&#x02013;59. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5482179/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23415091" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prog+Mol+Biol&#10;Transl+Sci&amp;title=Approaches+for+probing+allosteric+interactions+at+7&#10;transmembrane+spanning+receptors&amp;author=MT+Klein&amp;author=PN+Vinson&amp;author=CM+Niswender&amp;volume=115&amp;publication_year=2013&amp;pages=1-59&amp;pmid=23415091&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">[37] <span class="mixed-citation">Rodbell M, Birnbaumer L, Pohl SL, Krans HM, <span class="ref-title">The glucagon-sensitive adenyl cyclase system in plasma
membranes of rat liver. V. An obligatory role of guanylnucleotides in
glucagon action</span>, <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">246</span>(<span class="ref-iss">6</span>) (1971)
1877&#x02013;82. [<a href="https://pubmed.ncbi.nlm.nih.gov/4926550" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+glucagon-sensitive+adenyl+cyclase+system+in+plasma&#10;membranes+of+rat+liver.+V.+An+obligatory+role+of+guanylnucleotides+in&#10;glucagon+action&amp;author=M+Rodbell&amp;author=L+Birnbaumer&amp;author=SL+Pohl&amp;author=HM+Krans&amp;volume=246&amp;issue=6&amp;publication_year=1971&amp;pages=1877-82&amp;pmid=4926550&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">[38] <span class="mixed-citation">DeVree BT, Mahoney JP, Velez-Ruiz GA, Rasmussen SG, Kuszak AJ, Edwald E, Fung JJ, Manglik A, Masureel M, Du Y, Matt RA, Pardon E, Steyaert J, Kobilka BK, Sunahara RK, <span class="ref-title">Allosteric coupling from G protein to the
agonist-binding pocket in GPCRs</span>, <span class="ref-journal">Nature</span>
<span class="ref-vol">535</span>(<span class="ref-iss">7610</span>) (2016)
182&#x02013;6. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5702553/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27362234" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Allosteric+coupling+from+G+protein+to+the&#10;agonist-binding+pocket+in+GPCRs&amp;author=BT+DeVree&amp;author=JP+Mahoney&amp;author=GA+Velez-Ruiz&amp;author=SG+Rasmussen&amp;author=AJ+Kuszak&amp;volume=535&amp;issue=7610&amp;publication_year=2016&amp;pages=182-6&amp;pmid=27362234&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">[39] <span class="mixed-citation">Gossen D, Tastenoy M, Robberecht P, Christophe J, <span class="ref-title">Secretin receptors in the neuroglioma hybrid cell line
NG108&#x02013;15. Characterization and regulation of their
expression</span>, <span class="ref-journal">European journal of
biochemistry</span>
<span class="ref-vol">193</span>(<span class="ref-iss">1</span>) (1990)
149&#x02013;54. [<a href="https://pubmed.ncbi.nlm.nih.gov/2171930" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=European+journal+of&#10;biochemistry&amp;title=Secretin+receptors+in+the+neuroglioma+hybrid+cell+line&#10;NG108&#x02013;15.+Characterization+and+regulation+of+their&#10;expression&amp;author=D+Gossen&amp;author=M+Tastenoy&amp;author=P+Robberecht&amp;author=J+Christophe&amp;volume=193&amp;issue=1&amp;publication_year=1990&amp;pages=149-54&amp;pmid=2171930&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">[40] <span class="mixed-citation">Bauer MR, Joerger AC, Fersht AR, <span class="ref-title">2-Sulfonylpyrimidines: Mild alkylating agents with
anticancer activity toward p53-compromised cells</span>,
<span class="ref-journal">Proc Natl Acad Sci U S A</span>
<span class="ref-vol">113</span>(<span class="ref-iss">36</span>) (2016)
E5271&#x02013;80. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5018792/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27551077" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=2-Sulfonylpyrimidines:+Mild+alkylating+agents+with&#10;anticancer+activity+toward+p53-compromised+cells&amp;author=MR+Bauer&amp;author=AC+Joerger&amp;author=AR+Fersht&amp;volume=113&amp;issue=36&amp;publication_year=2016&amp;pages=E5271-80&amp;pmid=27551077&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">[41] <span class="mixed-citation">F&#x000f6;rster T, Shang E, Shimizu K, Sanada E, Sch&#x000f6;lermann B, Huebecker M, Hahne G, L&#x000f3;pez-Alberca MP, Janning P, Watanabe N, Sievers S, Giordanetto F, Shimizu T, Ziegler S, Osada H, Waldmann H, <span class="ref-title">2-Sulfonylpyrimidines Target the Kinesin HSET via
Cysteine Alkylation</span>, <span class="ref-journal">European Journal of Organic
Chemistry</span>
<span class="ref-vol">2019</span>(<span class="ref-iss">31&#x02013;32</span>) (2019)
5486&#x02013;5496. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=European+Journal+of+Organic&#10;Chemistry&amp;title=2-Sulfonylpyrimidines+Target+the+Kinesin+HSET+via&#10;Cysteine+Alkylation&amp;author=T+F&#x000f6;rster&amp;author=E+Shang&amp;author=K+Shimizu&amp;author=E+Sanada&amp;author=B+Sch&#x000f6;lermann&amp;volume=2019&amp;issue=31&#x02013;32&amp;publication_year=2019&amp;pages=5486-5496&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">[42] <span class="mixed-citation">Mulvihill EE, Drucker DJ, <span class="ref-title">Pharmacology, physiology, and mechanisms of action of
dipeptidyl peptidase-4 inhibitors</span>, <span class="ref-journal">Endocr
Rev</span>
<span class="ref-vol">35</span>(<span class="ref-iss">6</span>) (2014)
992&#x02013;1019. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7108477/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25216328" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr&#10;Rev&amp;title=Pharmacology,+physiology,+and+mechanisms+of+action+of&#10;dipeptidyl+peptidase-4+inhibitors&amp;author=EE+Mulvihill&amp;author=DJ+Drucker&amp;volume=35&amp;issue=6&amp;publication_year=2014&amp;pages=992-1019&amp;pmid=25216328&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">[43] <span class="mixed-citation">May LT, Leach K, Sexton PM, Christopoulos A, <span class="ref-title">Allosteric modulation of G protein-coupled
receptors</span>, <span class="ref-journal">Annu Rev Pharmacol Toxicol</span>
<span class="ref-vol">47</span> (2007)
1&#x02013;51. [<a href="https://pubmed.ncbi.nlm.nih.gov/17009927" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol+Toxicol&amp;title=Allosteric+modulation+of+G+protein-coupled&#10;receptors&amp;author=LT+May&amp;author=K+Leach&amp;author=PM+Sexton&amp;author=A+Christopoulos&amp;volume=47&amp;publication_year=2007&amp;pages=1-51&amp;pmid=17009927&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">[44] <span class="mixed-citation">Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S, <span class="ref-title">Crystal structure of the micro-opioid receptor bound to
a morphinan antagonist</span>, <span class="ref-journal">Nature</span>
<span class="ref-vol">485</span>(<span class="ref-iss">7398</span>) (2012)
321&#x02013;6. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3523197/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22437502" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Crystal+structure+of+the+micro-opioid+receptor+bound+to&#10;a+morphinan+antagonist&amp;author=A+Manglik&amp;author=AC+Kruse&amp;author=TS+Kobilka&amp;author=FS+Thian&amp;author=JM+Mathiesen&amp;volume=485&amp;issue=7398&amp;publication_year=2012&amp;pages=321-6&amp;pmid=22437502&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">[45] <span class="mixed-citation">Jones BJ, Scopelliti R, Tomas A, Bloom SR, Hodson DJ, Broichhagen J, <span class="ref-title">Potent Prearranged Positive Allosteric Modulators of the
Glucagon-like Peptide-1 Receptor</span>,
<span class="ref-journal">ChemistryOpen</span>
<span class="ref-vol">6</span>(<span class="ref-iss">4</span>) (2017)
501&#x02013;505. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5542757/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28794944" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ChemistryOpen&amp;title=Potent+Prearranged+Positive+Allosteric+Modulators+of+the&#10;Glucagon-like+Peptide-1+Receptor&amp;author=BJ+Jones&amp;author=R+Scopelliti&amp;author=A+Tomas&amp;author=SR+Bloom&amp;author=DJ+Hodson&amp;volume=6&amp;issue=4&amp;publication_year=2017&amp;pages=501-505&amp;pmid=28794944&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">[46] <span class="mixed-citation">Jones B, Buenaventura T, Kanda N, Chabosseau P, Owen BM, Scott R, Goldin R, Angkathunyakul N, Correa IR Jr., Bosco D, Johnson PR, Piemonti L, Marchetti P, Shapiro AMJ, Cochran BJ, Hanyaloglu AC, Inoue A, Tan T, Rutter GA, Tomas A, Bloom SR, <span class="ref-title">Targeting GLP-1 receptor trafficking to improve agonist
efficacy</span>, <span class="ref-journal">Nat Commun</span>
<span class="ref-vol">9</span>(<span class="ref-iss">1</span>) (2018)
1602. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5913239/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29686402" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Targeting+GLP-1+receptor+trafficking+to+improve+agonist&#10;efficacy&amp;author=B+Jones&amp;author=T+Buenaventura&amp;author=N+Kanda&amp;author=P+Chabosseau&amp;author=BM+Owen&amp;volume=9&amp;issue=1&amp;publication_year=2018&amp;pages=1602&amp;pmid=29686402&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">[47] <span class="mixed-citation">Buenaventura T, Bitsi S, Laughlin WE, Burgoyne T, Lyu Z, Oqua AI, Norman H, McGlone ER, Klymchenko AS, Correa IR Jr., Walker A, Inoue A, Hanyaloglu A, Grimes J, Koszegi Z, Calebiro D, Rutter GA, Bloom SR, Jones B, Tomas A, <span class="ref-title">Agonist-induced membrane nanodomain clustering drives
GLP-1 receptor responses in pancreatic beta cells</span>,
<span class="ref-journal">PLoS Biol</span>
<span class="ref-vol">17</span>(<span class="ref-iss">8</span>) (2019)
e3000097. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6716783/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31430273" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Biol&amp;title=Agonist-induced+membrane+nanodomain+clustering+drives&#10;GLP-1+receptor+responses+in+pancreatic+beta+cells&amp;author=T+Buenaventura&amp;author=S+Bitsi&amp;author=WE+Laughlin&amp;author=T+Burgoyne&amp;author=Z+Lyu&amp;volume=17&amp;issue=8&amp;publication_year=2019&amp;pages=e3000097&amp;pmid=31430273&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">[48] <span class="mixed-citation">Kopin AB, M., <span class="ref-journal">Methods and Compositions for the Treatment of Metabolic
Disorders</span>, USA,
2004. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Methods+and+Compositions+for+the+Treatment+of+Metabolic&#10;Disorders&amp;author=AB+Kopin&amp;author=+M.&amp;publication_year=2004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">[49] <span class="mixed-citation">Redij T, Ma J, Li Z, Hua X, Li Z, <span class="ref-title">Discovery of a potential positive allosteric modulator
of glucagon-like peptide 1 receptor through virtual screening and
experimental study</span>, <span class="ref-journal">J Comput Aided Mol Des</span>
<span class="ref-vol">33</span>(<span class="ref-iss">11</span>) (2019)
973&#x02013;981. [<a href="https://pubmed.ncbi.nlm.nih.gov/31758355" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Comput+Aided+Mol+Des&amp;title=Discovery+of+a+potential+positive+allosteric+modulator&#10;of+glucagon-like+peptide+1+receptor+through+virtual+screening+and&#10;experimental+study&amp;author=T+Redij&amp;author=J+Ma&amp;author=Z+Li&amp;author=X+Hua&amp;author=Z+Li&amp;volume=33&amp;issue=11&amp;publication_year=2019&amp;pages=973-981&amp;pmid=31758355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">[50] <span class="mixed-citation">Zhang Y, Sun B, Feng D, Hu H, Chu M, Qu Q, Tarrasch JT, Li S, Sun Kobilka T, Kobilka BK, Skiniotis G, <span class="ref-title">Cryo-EM structure of the activated GLP-1 receptor in
complex with a G protein</span>, <span class="ref-journal">Nature</span>
<span class="ref-vol">546</span>(<span class="ref-iss">7657</span>) (2017)
248&#x02013;253. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5587415/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28538729" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Cryo-EM+structure+of+the+activated+GLP-1+receptor+in&#10;complex+with+a+G+protein&amp;author=Y+Zhang&amp;author=B+Sun&amp;author=D+Feng&amp;author=H+Hu&amp;author=M+Chu&amp;volume=546&amp;issue=7657&amp;publication_year=2017&amp;pages=248-253&amp;pmid=28538729&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R51">[51] <span class="mixed-citation">Holst JJ, <span class="ref-title">The physiology of glucagon-like peptide
1</span>, <span class="ref-journal">Physiol Rev</span>
<span class="ref-vol">87</span>(<span class="ref-iss">4</span>) (2007)
1409&#x02013;39. [<a href="https://pubmed.ncbi.nlm.nih.gov/17928588" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Rev&amp;title=The+physiology+of+glucagon-like+peptide&#10;1&amp;author=JJ+Holst&amp;volume=87&amp;issue=4&amp;publication_year=2007&amp;pages=1409-39&amp;pmid=17928588&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R52">[52] <span class="mixed-citation">Kuna RS, Girada SB, Asalla S, Vallentyne J, Maddika S, Patterson JT, Smiley DL, DiMarchi RD, Mitra P, <span class="ref-title">Glucagon-like peptide-1 receptor-mediated endosomal cAMP
generation promotes glucose-stimulated insulin secretion in pancreatic
beta-cells</span>, <span class="ref-journal">Am J Physiol Endocrinol Metab</span>
<span class="ref-vol">305</span>(<span class="ref-iss">2</span>) (2013)
E161&#x02013;70. [<a href="https://pubmed.ncbi.nlm.nih.gov/23592482" ref="reftype=pubmed&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Endocrinol+Metab&amp;title=Glucagon-like+peptide-1+receptor-mediated+endosomal+cAMP&#10;generation+promotes+glucose-stimulated+insulin+secretion+in+pancreatic&#10;beta-cells&amp;author=RS+Kuna&amp;author=SB+Girada&amp;author=S+Asalla&amp;author=J+Vallentyne&amp;author=S+Maddika&amp;volume=305&amp;issue=2&amp;publication_year=2013&amp;pages=E161-70&amp;pmid=23592482&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8146373&amp;issue-id=382489&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8146373/pdf/nihms-1674663.pdf" class="int-view">PDF (4.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8146373/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8146373/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8146373" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8146373%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="BdjTxsGbOWwWHI8sBS0kO2bCKwF1W2X2AOpKO53O8oHTTmOhV3NHEyH5T3mzkTvc">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8146373%2F&amp;text=Discovery%20of%20small%20molecule%20positive%20allosteric%20modulators%20of%20the%0Asecretin%20receptor" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8146373%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146373/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8146373/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/33545115/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8146373/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/33545115/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8146373/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8146373/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC8146373/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
